@article {pmid33946120,
year = {2021},
author = {Elalamy, I and Gerotziafas, G and Alamowitch, S and Laroche, JP and Van Dreden, P and Ageno, W and Beyer-Westendorf, J and Cohen, AT and Jimenez, D and Brenner, B and Middeldorp, S and Cacoub, P and , },
title = {SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia.},
journal = {Thrombosis and haemostasis},
volume = {121},
number = {8},
pages = {982-991},
pmid = {33946120},
issn = {2567-689X},
mesh = {COVID-19/*prevention & control ; COVID-19 Vaccines/*adverse effects/therapeutic use ; Clinical Decision-Making ; Hemorrhage/etiology ; Humans ; Purpura, Thrombocytopenic, Idiopathic/*etiology ; Risk Factors ; Thrombocytopenia/etiology ; Thrombosis/*etiology ; Vaccination/adverse effects/methods ; },
abstract = {Historically, the vaccination strategies developed in the second half of the 20th century have facilitated the eradication of infectious diseases. From the onset of COVID-19 pandemic to the end of April 2021, more than 150 million cases and 3 million deaths were documented worldwide with disruption of the economic and social activity, and with devastating material, physical, and psychological consequences. Reports of unusual and severe thrombotic events, including cerebral and splanchnic venous thrombosis and other autoimmune adverse reactions, such as immune thrombocytopenia or thrombotic microangiopathies in connection with some of the SARS-CoV-2 vaccines, have caused a great deal of concern within the population and the medical community. This report is intended to provide practical answers following an overview of our knowledge on these thrombotic events that are extremely rare but have serious consequences. Vaccine hesitancy threatens to reverse the progress made in controlling vaccine-preventable diseases. These adverse events must be put into perspective with an objective analysis of the facts and the issues of the vaccination strategy during this SARS-CoV-2 pandemic. Health care professionals remain the most pertinent advisors and influencers regarding vaccination decisions; they have to be supported to provide reliable and credible information on vaccines. We need to inform, reassure, and support our patients when the prescription is made. Facing these challenges and observations, a panel of experts express their insights and propose a tracking algorithm for vaccinated patients based on a 10-point guideline for decision-making on what to do and not to do.},
}

COVID-19/*prevention & control
COVID-19 Vaccines/*adverse effects/therapeutic use
Clinical Decision-Making
Hemorrhage/etiology
Humans
Purpura, Thrombocytopenic, Idiopathic/*etiology
Risk Factors
Thrombocytopenia/etiology
Thrombosis/*etiology
Vaccination/adverse effects/methods

@article {pmid33941488,
year = {2021},
author = {Russo, FP and Piano, S and Bruno, R and Burra, P and Puoti, M and Masarone, M and Montagnese, S and Ponziani, FR and Petta, S and Aghemo, A and , },
title = {Italian association for the study of the liver position statement on SARS-CoV2 vaccination.},
journal = {Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver},
volume = {53},
number = {6},
pages = {677-681},
pmid = {33941488},
issn = {1878-3562},
mesh = {*COVID-19/epidemiology/prevention & control ; *COVID-19 Vaccines/classification/pharmacology ; Humans ; *Immunization Programs/methods/organization & administration ; Immunosuppressive Agents/therapeutic use ; Italy/epidemiology ; *Liver Diseases/immunology/therapy ; Liver Transplantation ; Patient Safety ; Patient Selection ; Risk Adjustment/*methods ; Risk Assessment ; SARS-CoV-2/immunology ; Transplant Recipients ; Treatment Outcome ; },
abstract = {The vaccination campaign against Sars-CoV-2 commenced in Italy at the end of December 2020. The first ones to receive the immunization against the virus were the health workers and the residents of nursing homes, following which the vaccine would be available for the entire population, beginning with the most vulnerable individuals. SARS-CoV2 vaccines have been demonstrated to be safe for the general population, although no data for patients with liver diseases or those having undergone liver transplantation are available so far. The present position statement AISF is an attempt to suggest, based on the published data on the impact of Sars-Cov-2 infection in patients with chronic liver disease, a possible priority for vaccination for this category of patients.},
}

*COVID-19/epidemiology/prevention & control
*COVID-19 Vaccines/classification/pharmacology
Humans
*Immunization Programs/methods/organization & administration
Immunosuppressive Agents/therapeutic use
Italy/epidemiology
*Liver Diseases/immunology/therapy
Liver Transplantation
Patient Safety
Patient Selection
Risk Adjustment/*methods
Risk Assessment
SARS-CoV-2/immunology
Transplant Recipients
Treatment Outcome

@article {pmid33909805,
year = {2021},
author = {Queiroz, NSF and Teixeira, FV and Freire, CCF and Motta, MP and Vasconcellos, MAM and Chebli, LA and Saad-Hossne, R and , },
title = {BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.},
journal = {Arquivos de gastroenterologia},
volume = {58},
number = {1},
pages = {1-4},
doi = {10.1590/S0004-2803.202100000-02},
pmid = {33909805},
issn = {1678-4219},
mesh = {Brazil ; *COVID-19 ; COVID-19 Vaccines ; Humans ; *Inflammatory Bowel Diseases ; Pandemics ; RNA, Viral ; SARS-CoV-2 ; Vaccination ; },
abstract = {Mass vaccination offers the best strategy to fight against COVID-19 pandemic, and SARS-CoV2 vaccines are being approved in several countries for emergency use. In Brazil, vaccine approval is expected in the next few days, however potential concerns exist regarding vaccine recommendations for specific populations, such as patients with inflammatory bowel disease (IBD). To address these questions, the Brazilian IBD Study Group (GEDIIB) provides this practical advice with key recommendations about the COVID-19 vaccines in IBD population.},
}

Brazil
*COVID-19
COVID-19 Vaccines
Humans
*Inflammatory Bowel Diseases
Pandemics
RNA, Viral
SARS-CoV-2
Vaccination

@article {pmid33909785,
year = {2021},
author = {Beck, ALS and Barberato, SH and Almeida, ALC and Grau, CRPC and Lopes, MMU and Lima, RSL and Cerci, RJ and Albricker, ACL and Barros, FS and Oliveira, AJ and Lira Filho, EB and Miglioranza, MH and Vieira, MLC and Pena, JLB and Strabelli, TMV and Bihan, DCSL and Tsutsui, JM and Rochitte, CE},
title = {Position Statement on Indications and the Safe Reintroduction of Cardiovascular Imaging Methods in the COVID-19 Scenario - 2021.},
journal = {Arquivos brasileiros de cardiologia},
volume = {116},
number = {3},
pages = {659-678},
pmid = {33909785},
issn = {1678-4170},
mesh = {Humans ; *Cardiovascular System ; *COVID-19 ; SARS-CoV-2 ; Societies, Medical ; },
}

Humans
*Cardiovascular System
*COVID-19
SARS-CoV-2
Societies, Medical

@article {pmid33887076,
year = {2021},
author = {Hegde, MN and Parmar, G and Logani, A and Hegde, ND and Ballal, S and Krithikadatta, J and Nawal, R and Amalavathy, K and Devadiga, D and Bhat, R},
title = {Dental practice management during COVID-19 times-Now and beyond.},
journal = {International journal of clinical practice},
volume = {75},
number = {9},
pages = {e14251},
pmid = {33887076},
issn = {1742-1241},
mesh = {*COVID-19 ; Humans ; Pandemics ; *Practice Management, Dental ; Public Health ; SARS-CoV-2 ; },
abstract = {AIM: Coronavirus disease 2019 (COVID-19) being declared a global public health emergency has become a significant challenge for all healthcare workers, including dentistry, recognised as a high-risk profession during these times. This consensus statement aims to highlight and provide guidelines necessary to be implemented for a clinical dental practice.

MATERIALS AND METHODS: A total of nine conservative Dentists and Endodontists and one Oral and Maxillofacial Surgeon; with four panelists from government dental colleges, one each from the North, South, East and West India and six resource persons from private colleges in South India, all of them being clinicians and administrators practicing dentistry since the inception of the pandemic, collaborated in this consensus statement. The consensus statement was developed through a symposium conducted on the topics; general dental practice during COVID-19 times, the importance of aerosols in clinical dental practice in the spread of COVID-19, effective standard operating protocols for clinical dental practice and Institutional settings with scientific evidence-based justifications, followed by a panel discussion with to devise mandatory protocols to be followed in clinical and institutional settings. The symposium was attended by 46 practitioners who participated in the deliberation.

RESULTS: This consensus statement provides clinicians and researchers with protocols for the dental practice, agreed upon by experts in the field. The Consensus Statement has been formulated according to the AGREE Reporting checklist for the formulation of guidelines.

CONCLUSION: The experts and panelists reached a Consensus on the protocols and guidelines for the safe clinical and institutional dental practice.},
}

*COVID-19
Humans
Pandemics
*Practice Management, Dental
Public Health
SARS-CoV-2

@article {pmid33861837,
year = {2020},
author = {Álvarez Z, P and Larios G, G and Toro R, L and Acevedo A, V and Arancibia G, F and Cárdenas M, L and Fernández C, C},
title = {[Recommendation for the recognition, management and follow up of cardiovascular compromise in patients with Pediatric Multisystemic Inflammatory Syndrome associated with COVID-19 (PIMS-CT). Position statement of Chilean Scientific Societies].},
journal = {Revista chilena de pediatria},
volume = {91},
number = {6},
pages = {982-990},
doi = {10.32641/rchped.vi91i6.3215},
pmid = {33861837},
issn = {0717-6228},
mesh = {Biomarkers/metabolism ; COVID-19/diagnosis/physiopathology/*therapy/complications ; Cardiovascular Diseases/diagnosis/therapy/*virology ; Child ; Chile ; Humans ; Mucocutaneous Lymph Node Syndrome/therapy/virology ; Patient Care Team/organization & administration ; Shock/therapy/virology ; Systemic Inflammatory Response Syndrome/diagnosis/physiopathology/*therapy ; },
abstract = {Since the onset of the SARS-CoV-2 pandemic, the pediatric population has been less affected by the disease both in frequency and severity. However, since April cases of variable presentation and severity characterized by inflammatory phenomena that affect multiple organs have been reported, a condition called Multisystem Inflammatory Syndrome in Children (MIS-C). The literature has reported frequent cardiac involvement, up to 80%. This is characterized by myocardial injury with a significant increase of biomarkers such as serum troponins I and T, BNP, or NT-ProBNP coupled with varying degrees of ventricular dysfunction, pericarditis, valvulitis, and arrhythmias. Coronary compromise has also been described, which can occur in up to 23% of cases, and ranges from dila tations to aneurysms. Inpatient and outpatient cardiology follow-up has been systematized based on the clinical phenotypes such as myocardial injury (myocarditis, valvulitis, pericarditis), shock (usua lly vasoplegic), Kawasaki disease-type manifestations, and those MIS-C that do not comply with the clinic of the previous three. This last group represents the main challenge in the short-, medium- and long-term follow-up, therefore, it is necessary a multidisciplinary team for managing these patients. Considering the high frequency of cardiac compromise in MIS-C, and the importance of reaching a consensus regarding its management and follow-up, we present these recommendations according to the current state of knowledge regarding this recently described pathology.},
}

Biomarkers/metabolism
COVID-19/diagnosis/physiopathology/*therapy/complications
Cardiovascular Diseases/diagnosis/therapy/*virology
Child
Chile
Humans
Mucocutaneous Lymph Node Syndrome/therapy/virology
Patient Care Team/organization & administration
Shock/therapy/virology
Systemic Inflammatory Response Syndrome/diagnosis/physiopathology/*therapy

@article {pmid33857654,
year = {2021},
author = {Ng, YS and Ong, PH and Mah, SM and Koh, CWC and Loh, YJ and Chew, E},
title = {Rehabilitation prioritization: Development of expert consensus on essential rehabilitation during pandemics.},
journal = {Annals of physical and rehabilitation medicine},
volume = {64},
number = {6},
pages = {101512},
pmid = {33857654},
issn = {1877-0665},
mesh = {Consensus ; Humans ; *Pandemics ; },
}

Consensus
Humans
*Pandemics

@article {pmid33855628,
year = {2021},
author = {Saibene, AM and Allevi, F and Ayad, T and Baudoin, T and Bernal-Sprekelsen, M and Briganti, G and Carrie, S and Cayé-Thomasen, P and Dahman Saidi, S and Dauby, N and Fenton, J and Golusiński, W and Klimek, L and Leclerc, AA and Longtin, Y and Mannelli, G and Mayo-Yáñez, M and Meço, C and Metwaly, O and Mouawad, F and Niemczyk, K and Pedersen, U and Piersiala, K and Plzak, J and Remacle, M and Rommel, N and Saleh, H and Szpecht, D and Tedla, M and Tincati, C and Tucciarone, M and Zelenik, K and Lechien, JR},
title = {Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement.},
journal = {European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery},
volume = {278},
number = {10},
pages = {4091-4099},
pmid = {33855628},
issn = {1434-4726},
mesh = {Breast Feeding ; *COVID-19 ; *COVID-19 Vaccines ; Consensus ; Female ; Humans ; Male ; *Otolaryngologists ; Pregnancy ; SARS-CoV-2 ; *Surgeons ; Vaccination ; },
abstract = {PURPOSE: SARS-CoV-2 vaccines are a key step in fighting the pandemic. Nevertheless, their rapid development did not allow for testing among specific population subgroups such as pregnant and breastfeeding women, or elaborating specific guidelines for healthcare personnel working in high infection risk specialties, such as otolaryngology (ORL). This clinical consensus statement (CCS) aims to offer guidance for SARS-CoV-2 vaccination to this high-risk population based on the best evidence available.

METHODS: A multidisciplinary international panel of 33 specialists judged statements through a two-round modified Delphi method survey. Statements were designed to encompass the following topics: risk of SARS-Cov-2 infection and use of protective equipment in ORL; SARS-Cov-2 infection and vaccines and respective risks for the mother/child dyad; and counseling for SARS-CoV-2 vaccination in pregnant, breastfeeding, or fertile healthcare workers (PBFHW). All ORL PBFHW were considered as the target audience.

RESULTS: Of the 13 statements, 7 reached consensus or strong consensus, 2 reached no consensus, and 2 reached near-consensus. According to the statements with strong consensus otorhinolaryngologists-head and neck surgeons who are pregnant, breastfeeding, or with childbearing potential should have the opportunity to receive SARS-Cov-2 vaccination. Moreover, personal protective equipment (PPE) should still be used even after the vaccination.

CONCLUSION: Until prospective evaluations on these topics are available, ORL-HNS must be considered a high infection risk specialty. While the use of PPE remains pivotal, ORL PBFHW should be allowed access to SARS-CoV-2 vaccination provided they receive up-to-date information.},
}

Breast Feeding
*COVID-19
*COVID-19 Vaccines
Consensus
Female
Humans
Male
*Otolaryngologists
Pregnancy
SARS-CoV-2
*Surgeons
Vaccination

@article {pmid33844898,
year = {2021},
author = {Martins, JRM and Villagelin, DGP and Carvalho, GA and Vaisman, F and Teixeira, PFS and Scheffel, RS and Sgarbi, JA},
title = {Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).},
journal = {Archives of endocrinology and metabolism},
volume = {65},
number = {3},
pages = {368-375},
pmid = {33844898},
issn = {2359-4292},
mesh = {Brazil ; *COVID-19 ; Graves Ophthalmopathy/therapy ; Humans ; Hyperthyroidism/therapy ; Iodine Radioisotopes ; Pandemics ; Thyroid Diseases/*therapy ; Thyroid Gland ; },
abstract = {This position statement was prepared to guide endocrinologists on the best approach to managing thyroid disorders during the coronavirus disease (COVID-19) pandemic. The most frequent thyroid hormonal findings in patients with COVID-19, particularly in individuals with severe disease, are similar to those present in the non-thyroidal illness syndrome and require no intervention. Subacute thyroiditis has also been reported during COVID-19 infection. Diagnosis and treatment of hypothyroidism during the COVID-19 pandemic may follow usual practice; however, should avoid frequent laboratory tests in patients with previous controlled disease. Well-controlled hypo and hyperthyroidism are not associated with an increased risk of COVID-19 infection or severity. Newly diagnosed hyperthyroidism during the pandemic should be preferably treated with antithyroid drugs (ATDs), bearing in mind the possibility of rare side effects with these medications, particularly agranulocytosis, which requires immediate intervention. Definitive treatment of hyperthyroidism (radioiodine therapy or surgery) may be considered in those cases that protective protocols can be followed to avoid COVID-19 contamination or once the pandemic is over. In patients with moderate Graves' ophthalmopathy (GO) not at risk of visual loss, glucocorticoids at immunosuppressive doses should be avoided, while in those with severe GO without COVID-19 and at risk of vision loss, intravenous glucocorticoid is the therapeutic choice. Considering that most of the thyroid cancer cases are low risk and associated with an excellent prognosis, surgical procedures could and should be postponed safely during the pandemic period. Additionally, when indicated, radioiodine therapy could also be safely postponed as long as it is possible.},
}

Brazil
*COVID-19
Graves Ophthalmopathy/therapy
Humans
Hyperthyroidism/therapy
Iodine Radioisotopes
Pandemics
Thyroid Diseases/*therapy
Thyroid Gland

@article {pmid33844056,
year = {2021},
author = {Centonze, D and Rocca, MA and Gasperini, C and Kappos, L and Hartung, HP and Magyari, M and Oreja-Guevara, C and Trojano, M and Wiendl, H and Filippi, M},
title = {Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus.},
journal = {Journal of neurology},
volume = {268},
number = {11},
pages = {3961-3968},
pmid = {33844056},
issn = {1432-1459},
mesh = {*COVID-19 ; COVID-19 Vaccines ; Consensus ; Humans ; *Multiple Sclerosis/drug therapy ; SARS-CoV-2 ; Vaccination ; },
abstract = {Coronavirus disease (COVID-19) appeared in December 2019 in the Chinese city of Wuhan and has quickly become a global pandemic. The disease is caused by the severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2), an RNA beta coronavirus phylogenetically similar to SARS coronavirus. To date, more than 132 million cases of COVID19 have been recorded in the world, of which over 2.8 million were fatal (https://coronavirus.jhu.edu/map.html). A huge vaccination campaign has started around the world since the end of 2020. The availability of vaccines has raised some concerns among neurologists regarding the safety and efficacy of vaccination in patients with multiple sclerosis (MS) taking immunomodulatory or immunosuppressive therapies.},
}

*COVID-19
COVID-19 Vaccines
Consensus
Humans
*Multiple Sclerosis/drug therapy
SARS-CoV-2
Vaccination

@article {pmid33839767,
year = {2021},
author = {Badimon, L and Robinson, EL and Jusic, A and Carpusca, I and deWindt, LJ and Emanueli, C and Ferdinandy, P and Gu, W and Gyöngyösi, M and Hackl, M and Karaduzovic-Hadziabdic, K and Lustrek, M and Martelli, F and Nham, E and Potočnjak, I and Satagopam, V and Schneider, R and Thum, T and Devaux, Y},
title = {Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129.},
journal = {Cardiovascular research},
volume = {117},
number = {8},
pages = {1823-1840},
pmid = {33839767},
issn = {1755-3245},
support = {CH/15/1/31199/BHF_/British Heart Foundation/United Kingdom ; RG/20/9/35101/BHF_/British Heart Foundation/United Kingdom ; },
mesh = {Artificial Intelligence/*economics ; Biomarkers/*analysis ; COVID-19/*diagnosis ; Cardiovascular Diseases/diagnosis/genetics ; Cardiovascular System/virology ; Humans ; Quality of Life ; RNA/*genetics ; SARS-CoV-2/pathogenicity ; },
abstract = {The coronavirus disease 2019 (COVID-19) pandemic has been as unprecedented as unexpected, affecting more than 105 million people worldwide as of 8 February 2020 and causing more than 2.3 million deaths according to the World Health Organization (WHO). Not only affecting the lungs but also provoking acute respiratory distress, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is able to infect multiple cell types including cardiac and vascular cells. Hence a significant proportion of infected patients develop cardiac events, such as arrhythmias and heart failure. Patients with cardiovascular comorbidities are at highest risk of cardiac death. To face the pandemic and limit its burden, health authorities have launched several fast-track calls for research projects aiming to develop rapid strategies to combat the disease, as well as longer-term projects to prepare for the future. Biomarkers have the possibility to aid in clinical decision-making and tailoring healthcare in order to improve patient quality of life. The biomarker potential of circulating RNAs has been recognized in several disease conditions, including cardiovascular disease. RNA biomarkers may be useful in the current COVID-19 situation. The discovery, validation, and marketing of novel biomarkers, including RNA biomarkers, require multi-centre studies by large and interdisciplinary collaborative networks, involving both the academia and the industry. Here, members of the EU-CardioRNA COST Action CA17129 summarize the current knowledge about the strain that COVID-19 places on the cardiovascular system and discuss how RNA biomarkers can aid to limit this burden. They present the benefits and challenges of the discovery of novel RNA biomarkers, the need for networking efforts, and the added value of artificial intelligence to achieve reliable advances.},
}

Artificial Intelligence/*economics
Biomarkers/*analysis
COVID-19/*diagnosis
Cardiovascular Diseases/diagnosis/genetics
Cardiovascular System/virology
Humans
Quality of Life
RNA/*genetics
SARS-CoV-2/pathogenicity

@article {pmid33837003,
year = {2021},
author = {Weiler, R and Blauwet, C and Clarke, D and Dalton, K and Derman, W and Fagher, K and Gouttebarge, V and Kissick, J and Lee, K and Lexell, J and Van de Vliet, P and Verhagen, E and Webborn, N and Ahmed, OH},
title = {Concussion in para sport: the first position statement of the Concussion in Para Sport (CIPS) Group.},
journal = {British journal of sports medicine},
volume = {55},
number = {21},
pages = {1187-1195},
pmid = {33837003},
issn = {1473-0480},
mesh = {*Athletes ; Athletic Injuries/*complications ; *Brain Concussion ; Persons with Disabilities ; Humans ; *Sports for Persons with Disabilities ; },
abstract = {Concussion is a frequent injury in many sports and is also common in para athletes. However, there is a paucity of concussion research related to para sport, and prior International Concussion in Sport (CIS) consensus papers have not substantively addressed this population. To remedy this and to improve concussion care provided to para athletes, the concussion in para sport (CIPS) multidisciplinary expert group was created. This group analysed and discussed in-depth para athlete-specific issues within the established key clinical domains of the current (2017) consensus statement on CIS. Due to the onset of the COVID-19 pandemic, the group held all meetings by video conferencing. The existing Sport Concussion Assessment Tool 5 (SCAT5) for the immediate on-field and office-based off-field assessment of concussion was evaluated as part of this process, to identify any para athlete-specific concerns. Regular preparticipation and periodic health examinations are essential to determine a baseline reference point for concussion symptoms but pose additional challenges for the interpreting clinician. Further considerations for concussion management for the para athlete are required within the remove, rest, reconsider and refer consensus statement framework. Considering return to sport (RTS), the 2017 CIS consensus statement has limitations when considering the RTS of the para athlete. Case-by-case decision making related to RTS following concussion is imperative for para athletes. Additional challenges exist for the evaluation and management of concussion in para athletes. There is a need for greater understanding of existing knowledge gaps and attitudes towards concussion among athlete medical staff, coaches and para athletes. Future research should investigate the use and performance of common assessment tools in the para athlete population to better guide their clinical application and inform potential modifications. Concussion prevention strategies and sport-specific rule changes, such as in Para Alpine Skiing and Cerebral Palsy Football, also should be carefully considered to reduce the occurrence of concussion in para athletes.},
}

*Athletes
Athletic Injuries/*complications
*Brain Concussion
Persons with Disabilities
Humans
*Sports for Persons with Disabilities

@article {pmid33820898,
year = {2021},
author = {Rodrigues, AM and Romeu, JC and Canas da Silva, J and Tavares-Costa, J and Faustino, A and Vaz, C and Pereira da Silva, JA and Canhão, H},
title = {Osteoporosis management during the COVID-19 pandemic - Position paper.},
journal = {Acta reumatologica portuguesa},
volume = {46},
number = {1},
pages = {55-57},
pmid = {33820898},
issn = {2184-8777},
mesh = {*COVID-19 ; Humans ; Osteoporosis/*therapy ; },
abstract = {COVID-19 pandemic significantly increased the already large number of victims of osteoporosis in Portugal. Osteoporosis outpatient clinics were either closed or had limited presential appointments. Many hospitals reduced orthopaedic services to make space for patients with COVID-19. In addition, the volunteer or forced sedentarism, as imposed by the pandemic, increased the risk of falls and fractures drastically. It urges to intensify the current efforts to improve the management of bone health and to prioritize fragility fracture care and prevention. This paper addresses the challenges in osteoporosis management during the COVID-19 pandemic and provides guidance on osteoporosis management. This position paper is a joint initiative of several health professionals and patients dedicated to osteoporosis.},
}

*COVID-19
Humans
Osteoporosis/*therapy

@article {pmid33797444,
year = {2021},
author = {Silva, CF and Alegria, J and Ramos, C and Verdugo, J and Diaz, JC and Varela, C and Barbe, M},
title = {RSNA-STR-ACR Consensus Statement for COVID-19 CT Patterns: Interreader Agreement in 240 Consecutive Patients and Association With RT-PCR Status.},
journal = {Journal of computer assisted tomography},
volume = {45},
number = {3},
pages = {485-489},
doi = {10.1097/RCT.0000000000001162},
pmid = {33797444},
issn = {1532-3145},
mesh = {Adult ; Aged ; Aged, 80 and over ; COVID-19/*diagnosis ; Consensus ; Female ; Humans ; Male ; Middle Aged ; Observer Variation ; Radiographic Image Interpretation, Computer-Assisted/*standards ; Retrospective Studies ; Reverse Transcriptase Polymerase Chain Reaction/*standards ; Severity of Illness Index ; Tomography, X-Ray Computed/*standards ; Young Adult ; },
abstract = {PURPOSE: The aim of this study was to study interreader agreement of the RSNA-STR-ACR (Radiological Society of North America/Society of Thoracic Radiology/American College of Radiology) consensus statement on reporting chest computed tomography (CT) findings related to COVID-19 on a sample of consecutive patients confirmed with reverse transcriptase-polymerase chain reaction (RT-PCR) for severe acute respiratory syndrome coronavirus 2.

MATERIALS AND METHODS: This institutional review board-approved retrospective study included 240 cases with a mean age of 47.6 ± 15.9 years, ranging from 20 to 90 years, who had a chest CT and RT-PCR performed. Computed tomography images were independently analyzed by 2 thoracic radiologists to identify patterns defined by the RSNA-STR-ACR consensus statement, and concordance was determined with weighted κ tests. Also, CT findings and CT severity scores were tabulated and compared.

RESULTS: Of the 240 cases, 118 had findings on CT. The most frequent on the RT-PCR-positive group were areas of ground-glass opacities (80.5%), crazy-paving pattern (32.2%), and rounded pseudonodular ground-glass opacities (22.9%). Regarding the CT patterns, the most frequent in the RT-PCR-positive group was typical in 75.9%, followed by negative in 17.1%. The interreader agreement was 0.90 (95% confidence interval, 0.80-0.96) in this group. The CT severity score had a mean difference of -0.07 (95% confidence interval, -0.48 to 0.34) among the readers, showing no significant differences regarding visual estimation.

CONCLUSIONS: The RSNA-STR-ACR consensus statement on reporting chest CT patterns for COVID-19 presents a high interreader agreement, with the typical pattern being more frequently associated with RT-PCR-positive examinations.},
}

Adult
Aged
Aged, 80 and over
COVID-19/*diagnosis
Consensus
Female
Humans
Male
Middle Aged
Observer Variation
Radiographic Image Interpretation, Computer-Assisted/*standards
Retrospective Studies
Reverse Transcriptase Polymerase Chain Reaction/*standards
Severity of Illness Index
Tomography, X-Ray Computed/*standards
Young Adult

@article {pmid33795490,
year = {2021},
author = {Alharbi, AS and Alzahrani, M and Alodayani, AN and Alhindi, MY and Alharbi, S and Alnemri, A},
title = {Saudi experts' recommendation for RSV prophylaxis in the era of COVID-19: Consensus from the Saudi Pediatric Pulmonology Association.},
journal = {Saudi medical journal},
volume = {42},
number = {4},
pages = {355-362},
pmid = {33795490},
issn = {1658-3175},
mesh = {Advisory Committees ; Antiviral Agents/*therapeutic use ; Bronchiolitis, Viral/*prevention & control ; COVID-19/epidemiology/prevention & control ; Delivery of Health Care/*methods ; Home Care Services ; Humans ; Immunization Programs/*methods ; Infant ; Infant, Newborn ; Injections ; Palivizumab/*therapeutic use ; Pulmonary Medicine ; Respiratory Syncytial Virus Infections/*prevention & control ; SARS-CoV-2 ; Saudi Arabia ; Societies, Medical ; },
abstract = {Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and viral pneumonia in pediatrics worldwide. In the Kingdom of Saudi Arabia (KSA), the prevalence of RSV is 23.5% in pediatric patients with acute lower respiratory tract illness. Coronavirus disease (COVID-19) poses critical public health and socioeconomic challenges in KSA. The Saudi Pediatric Pulmonology Association (SPPA), a subsidiary of the Saudi Thoracic Society (STS), developed a task force to determine the potential challenges and barriers to the RSV immunoprophylaxis program during the era of COVID-19 and to compose a practical, nationwide, and multidisciplinary approach to address these challenges. Some of the recommendations to manage these challenges include increasing the number of RSV immunoprophylaxis clinics, drive-thru visits, home-care services, and swift referrals to the RSV immunoprophylaxis program specialists. Additional training is required for healthcare personnel to add RSV immunoprophylaxis to the regular immunization schedule.},
}

Advisory Committees
Antiviral Agents/*therapeutic use
Bronchiolitis, Viral/*prevention & control
COVID-19/epidemiology/prevention & control
Delivery of Health Care/*methods
Home Care Services
Humans
Immunization Programs/*methods
Infant
Infant, Newborn
Injections
Palivizumab/*therapeutic use
Pulmonary Medicine
Respiratory Syncytial Virus Infections/*prevention & control
SARS-CoV-2
Saudi Arabia
Societies, Medical

@article {pmid33780557,
year = {2021},
author = {Arenbergerova, M and Lallas, A and Nagore, E and Rudnicka, L and Forsea, AM and Pasek, M and Meier, F and Peris, K and Olah, J and Posch, C},
title = {Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19.},
journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
volume = {35},
number = {7},
pages = {e427-e428},
pmid = {33780557},
issn = {1468-3083},
support = {PROGRES Q28//Charles University, Prague, Czech Republic/ ; },
mesh = {*COVID-19 ; Humans ; *Melanoma/therapy ; SARS-CoV-2 ; *Skin Neoplasms/therapy ; },
}

*COVID-19
Humans
*Melanoma/therapy
SARS-CoV-2
*Skin Neoplasms/therapy

@article {pmid33766471,
year = {2021},
author = {Guarracino, F and Shernan, SK and Tahan, ME and Bertini, P and Stone, ME and Kachulis, B and Paternoster, G and Mukherjee, C and Wouters, P and Rex, S},
title = {EACTA/SCA Recommendations for the Cardiac Anesthesia Management of Patients With Suspected or Confirmed COVID-19 Infection: An Expert Consensus From the European Association of Cardiothoracic Anesthesiology and Society of Cardiovascular Anesthesiologists With Endorsement From the Chinese Society of Cardiothoracic and Vascular Anesthesiology.},
journal = {Journal of cardiothoracic and vascular anesthesia},
volume = {35},
number = {7},
pages = {1953-1963},
pmid = {33766471},
issn = {1532-8422},
mesh = {*Anesthesia, Cardiac Procedures ; Anesthesiologists ; *Anesthesiology ; *COVID-19 ; China ; Consensus ; Humans ; Pandemics ; SARS-CoV-2 ; },
abstract = {The European Association of Cardiothoracic Anaesthesiology (EACTA) and the Society of Cardiovascular Anesthesiologists (SCA) aimed to create joint recommendations for the perioperative management of patients with suspected or proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection undergoing cardiac surgery or invasive cardiac procedures. To produce appropriate recommendations, the authors combined the evidence from the literature review, reevaluating the clinical experience of routine cardiac surgery in similar cases during the Middle East Respiratory Syndrome (MERS-CoV) outbreak and the current pandemic with suspected coronavirus disease 2019 (COVID-19) patients, and the expert opinions through broad discussions within the EACTA and SCA. The authors took into consideration the balance between established procedures and the feasibility during the present outbreak. The authors present an agreement between the European and US practices in managing patients during the COVID-19 pandemic. The recommendations take into consideration a broad spectrum of issues, with a focus on preoperative testing, safety concerns, overall approaches to general and specific aspects of preparation for anesthesia, airway management, transesophageal echocardiography, perioperative ventilation, coagulation, hemodynamic control, and postoperative care. As the COVID-19 pandemic is spreading, it will continue to present a challenge for the worldwide anesthesiology community. To allow these recommendations to be updated as long as possible, the authors provided weblinks to international public and academic sources providing timely updated data. This document should be the basis of future task forces to develop a more comprehensive consensus considering new evidence uncovered during the COVID-19 pandemic.},
}

*Anesthesia, Cardiac Procedures
Anesthesiologists
*Anesthesiology
*COVID-19
China
Consensus
Humans
Pandemics
SARS-CoV-2

@article {pmid33766426,
year = {2021},
author = {Gallo, G and Grossi, U and Sturiale, A and Di Tanna, GL and Picciariello, A and Pillon, S and Mascagni, D and Altomare, DF and Naldini, G and Perinotti, R and , },
title = {E-consensus on telemedicine in proctology: A RAND/UCLA-modified study.},
journal = {Surgery},
volume = {170},
number = {2},
pages = {405-411},
doi = {10.1016/j.surg.2021.01.049},
pmid = {33766426},
issn = {1532-7361},
mesh = {Colorectal Surgery/*standards ; Female ; Humans ; Male ; Middle Aged ; Telemedicine/*standards ; },
abstract = {BACKGROUND: Coronavirus disease 2019 is revolutionizing healthcare delivery. The aim of this study was to reach a consensus among experts as to the possible applications of telemedicine in the proctologic field.

METHODS: A group of 55 clinical practice recommendations was developed by a clinical guidance group based on coalescence of evidence and expert opinion. The Telemedicine in Proctology Italian Working Group included 47 Italian Society of Colorectal Surgery nominated experts evaluating the appropriateness of each clinical practice recommendations based on published RAND/UCLA methodology in 2 rounds.

RESULTS: Stakeholder median age was 53 years (interquartile range limits 40-60), and 38 (81%) were men. Nine (19%) panelists reported no experience with telemedicine before the pandemic. Agreement was obtained on a minimum of 3 to 5 years of practice in the proctologic field before starting teleconsultations, which should be regularly paid, with advice and prescriptions incorporated into a formal report sent to the patient by e-mail along with a receipt. Of the panelists, 35 of 47 (74%) agreed that teleconsultation carries the risk of misdiagnosis of cancer, thus recommending an in-person assessment before scheduling any surgery. Fifteen additional clinical practice recommendations were re-elaborated in the second round and assessed by 44 of 47 (93.6%) panelists. The application of telemedicine for the diagnosis of common proctologic conditions (eg, hemorrhoidal disease, anal abscess and fistula, anal condylomas, and anal fissure) and functional pelvic floor disorders was generally considered inappropriate. Teleconsultation was instead deemed appropriate for the diagnosis and management of pilonidal disease.

CONCLUSION: This e-consensus revealed the boundaries of telemedicine in Italy. Standardization of infrastructures, logistics, and legality remain to be better elucidated.},
}

Colorectal Surgery/*standards
Female
Humans
Male
Middle Aged
Telemedicine/*standards

@article {pmid33752263,
year = {2021},
author = {Ring, J and Worm, M and Wollenberg, A and Thyssen, JP and Jakob, T and Klimek, L and Bangert, C and Barbarot, S and Bieber, T and de Bruin-Weller, MS and Chernyshov, PV and Christen-Zaech, S and Cork, M and Darsow, U and Flohr, C and Fölster-Holst, R and Gelmetti, C and Gieler, U and Gutermuth, J and Heratizadeh, A and Hijnen, DJ and von Kobyletzki, LB and Kunz, B and Paul, C and De Raeve, L and Seneschal, J and Simon, D and Spuls, PI and Stalder, JF and Svensson, A and Szalai, Z and Taieb, A and Torrelo, A and Trzeciak, M and Vestergaard, C and Werfel, T and Weidinger, S and Deleuran, M},
title = {Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.},
journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
volume = {35},
number = {6},
pages = {e362-e365},
pmid = {33752263},
issn = {1468-3083},
mesh = {*Anaphylaxis ; *COVID-19 ; COVID-19 Vaccines ; *Dermatitis, Atopic/prevention & control ; Humans ; SARS-CoV-2 ; *Vaccines ; },
}

*Anaphylaxis
*COVID-19
COVID-19 Vaccines
*Dermatitis, Atopic/prevention & control
Humans
SARS-CoV-2
*Vaccines

@article {pmid33726819,
year = {2021},
author = {Nasa, P and Azoulay, E and Khanna, AK and Jain, R and Gupta, S and Javeri, Y and Juneja, D and Rangappa, P and Sundararajan, K and Alhazzani, W and Antonelli, M and Arabi, YM and Bakker, J and Brochard, LJ and Deane, AM and Du, B and Einav, S and Esteban, A and Gajic, O and Galvagno, SM and Guérin, C and Jaber, S and Khilnani, GC and Koh, Y and Lascarrou, JB and Machado, FR and Malbrain, MLNG and Mancebo, J and McCurdy, MT and McGrath, BA and Mehta, S and Mekontso-Dessap, A and Mer, M and Nurok, M and Park, PK and Pelosi, P and Peter, JV and Phua, J and Pilcher, DV and Piquilloud, L and Schellongowski, P and Schultz, MJ and Shankar-Hari, M and Singh, S and Sorbello, M and Tiruvoipati, R and Udy, AA and Welte, T and Myatra, SN},
title = {Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method.},
journal = {Critical care (London, England)},
volume = {25},
number = {1},
pages = {106},
pmid = {33726819},
issn = {1466-609X},
mesh = {COVID-19/*complications ; *Consensus ; *Delphi Technique ; Humans ; Respiratory Insufficiency/*therapy/*virology ; },
abstract = {BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented pressure on healthcare system globally. Lack of high-quality evidence on the respiratory management of COVID-19-related acute respiratory failure (C-ARF) has resulted in wide variation in clinical practice.

METHODS: Using a Delphi process, an international panel of 39 experts developed clinical practice statements on the respiratory management of C-ARF in areas where evidence is absent or limited. Agreement was defined as achieved when > 70% experts voted for a given option on the Likert scale statement or > 80% voted for a particular option in multiple-choice questions. Stability was assessed between the two concluding rounds for each statement, using the non-parametric Chi-square (χ[2]) test (p < 0·05 was considered as unstable).

RESULTS: Agreement was achieved for 27 (73%) management strategies which were then used to develop expert clinical practice statements. Experts agreed that COVID-19-related acute respiratory distress syndrome (ARDS) is clinically similar to other forms of ARDS. The Delphi process yielded strong suggestions for use of systemic corticosteroids for critical COVID-19; awake self-proning to improve oxygenation and high flow nasal oxygen to potentially reduce tracheal intubation; non-invasive ventilation for patients with mixed hypoxemic-hypercapnic respiratory failure; tracheal intubation for poor mentation, hemodynamic instability or severe hypoxemia; closed suction systems; lung protective ventilation; prone ventilation (for 16-24 h per day) to improve oxygenation; neuromuscular blocking agents for patient-ventilator dyssynchrony; avoiding delay in extubation for the risk of reintubation; and similar timing of tracheostomy as in non-COVID-19 patients. There was no agreement on positive end expiratory pressure titration or the choice of personal protective equipment.

CONCLUSION: Using a Delphi method, an agreement among experts was reached for 27 statements from which 20 expert clinical practice statements were derived on the respiratory management of C-ARF, addressing important decisions for patient management in areas where evidence is either absent or limited.

TRIAL REGISTRATION: The study was registered with Clinical trials.gov Identifier: NCT04534569.},
}

COVID-19/*complications
*Consensus
*Delphi Technique
Humans
Respiratory Insufficiency/*therapy/*virology

@article {pmid33685875,
year = {2021},
author = {Dambha-Miller, H and Griffin, SJ and Young, D and Watkinson, P and Tan, PS and Clift, AK and Payne, RA and Coupland, C and Hopewell, JC and Mant, J and Martin, RM and Hippisley-Cox, J},
title = {The Use of Primary Care Big Data in Understanding the Pharmacoepidemiology of COVID-19: A Consensus Statement From the COVID-19 Primary Care Database Consortium.},
journal = {Annals of family medicine},
volume = {19},
number = {2},
pages = {135-140},
pmid = {33685875},
issn = {1544-1717},
support = {29019/CRUK_/Cancer Research UK/United Kingdom ; MC_UU_00006/6/MRC_/Medical Research Council/United Kingdom ; MC_UU_12015/4/MRC_/Medical Research Council/United Kingdom ; MR/V027778/1/MRC_/Medical Research Council/United Kingdom ; },
mesh = {Big Data ; COVID-19/diagnosis/*epidemiology ; *Consensus ; Databases, Factual/*standards ; Humans ; Medical Records Systems, Computerized/*standards ; Pharmacoepidemiology ; Primary Health Care/*organization & administration ; Public Health ; *Public Health Surveillance ; United Kingdom/epidemiology ; },
abstract = {The use of big data containing millions of primary care medical records provides an opportunity for rapid research to help inform patient care and policy decisions during the first and subsequent waves of the coronavirus disease 2019 (COVID-19) pandemic. Routinely collected primary care data have previously been used for national pandemic surveillance, quantifying associations between exposures and outcomes, identifying high risk populations, and examining the effects of interventions at scale, but there is no consensus on how to effectively conduct or report these data for COVID-19 research. A COVID-19 primary care database consortium was established in April 2020 and its researchers have ongoing COVID-19 projects in overlapping data sets with over 40 million primary care records in the United Kingdom that are variously linked to public health, secondary care, and vital status records. This consensus agreement is aimed at facilitating transparency and rigor in methodological approaches, and consistency in defining and reporting cases, exposures, confounders, stratification variables, and outcomes in relation to the pharmacoepidemiology of COVID-19. This will facilitate comparison, validation, and meta-analyses of research during and after the pandemic.},
}

Big Data
COVID-19/diagnosis/*epidemiology
*Consensus
Databases, Factual/*standards
Humans
Medical Records Systems, Computerized/*standards
Pharmacoepidemiology
Primary Health Care/*organization & administration
Public Health
*Public Health Surveillance
United Kingdom/epidemiology

@article {pmid33642133,
year = {2021},
author = {Tarazona-Santabalbina, FJ and Cuadra, L and Cancio, JM and Carbonell, FR and Garrote, JMP and Casas-Herrero, Á and Martínez-Velilla, N and Serra-Rexach, JA and Formiga, F},
title = {VitaminD supplementation for the prevention and treatment of COVID-19: a position statement from the Spanish Society of Geriatrics and Gerontology.},
journal = {Revista espanola de geriatria y gerontologia},
volume = {56},
number = {3},
pages = {177-182},
pmid = {33642133},
issn = {1578-1747},
mesh = {Aged ; COVID-19/complications/immunology/prevention & control/*therapy ; *Cytokine Release Syndrome/prevention & control ; *Dietary Supplements ; *Geriatrics ; Humans ; Receptors, Calcitriol/metabolism ; Societies, Medical ; Spain ; Vitamin D/*administration & dosage/immunology ; Vitamin D Deficiency/complications/*therapy ; Vitamins/*administration & dosage/immunology ; },
abstract = {The coronavirus disease 2019 (COVID-19) produces severe respiratory symptoms such as bilateral pneumonia associated to a high morbidity and mortality, especially in patients of advanced age. Vitamin D deficiency has been reported in several chronic conditions associated with increased inflammation and dysregulation of the immune system. Vitamin D in modulates immune function too. Vitamin D receptor (VDR) is expressed by most immune cells, including B and T lymphocytes, monocytes, macrophages, and dendritic cells and the signalling of vitamin D and VDR together has an anti-inflammatory effect. Some studies have reported that vitamin D treatment could be useful for the prevention and treatment of COVID-19 because vitamin D plays an important role as a modulator of immunocompetence. Over the last few months, some studies have hypothesized the possible beneficial effect of vitamin D supplementation in patients with COVID-19 in order to improve the immune balance and prevent the hyperinflammatory cytokine storm. Some preliminary studies have already shown promising results with vitamin D supplementation in hospitalized COVID-19 patients. Vitamin D should be administered daily until adequate levels are achieved due to vitamin D behaves as a negative acute phase reactant (APR). Despite the lack of evidence on specific doses of vitamin D to treat COVID-19 in older adults, authors consider it is necessary to standardize the use in clinical practice. These recommendations advice supplement vitamin D in a protocoled fashion based on expert opinions, level of evidence 5.},
}

Aged
COVID-19/complications/immunology/prevention & control/*therapy
*Cytokine Release Syndrome/prevention & control
*Dietary Supplements
*Geriatrics
Humans
Receptors, Calcitriol/metabolism
Societies, Medical
Spain
Vitamin D/*administration & dosage/immunology
Vitamin D Deficiency/complications/*therapy
Vitamins/*administration & dosage/immunology

@article {pmid33641834,
year = {2021},
author = {Jain, M and Rajpal, S and Arora, VK and Bhargav, S and Chopra, KK},
title = {White paper on challenges and opportunities for TB elimination with focus on COVID & Post-COVID era developed through scientific roundtable resolutions at NATCON 2020.},
journal = {The Indian journal of tuberculosis},
volume = {68},
number = {1},
pages = {134-138},
pmid = {33641834},
issn = {0019-5707},
mesh = {*COVID-19 ; Congresses as Topic ; *Epidemics ; Global Health ; Humans ; National Health Programs ; *SARS-CoV-2 ; Tuberculosis, Pulmonary/*prevention & control ; },
abstract = {A group of TB experts with vast clinical and epidemiological experience were drawn from a pool of doctors, epidemiologists and scientists participating in NATCON 2020 Conference in a closed-door session to discuss, highlight, and prioritize key resolutions that are most pertinent at present to eliminate TB from India and other developing countries in the Covid and post-COVID era. These Scientific experts were non-industry persons who met on 17th December, 2020 and used the prevailing scientific literature along with 2019 Joint Monitoring Mission document as a starting point of the discussion on this specific topic to build an agreement upon the resolutions. After the meeting on the virtual platform, all the attending doctors gave a set of recommendations on rebuilding TB Elimination programme in the Covid and Post-Covid era. Focused scientific roundtable discussion on rebuilding TB Elimination Post-Covid. Develop actionable recommendations for the scientific community and the government leadership to consider in moving forward. To prioritize the recommendations in the categories of Build-Prevent-Detect-Treat.},
}

*COVID-19
Congresses as Topic
*Epidemics
Global Health
Humans
National Health Programs
*SARS-CoV-2
Tuberculosis, Pulmonary/*prevention & control

@article {pmid33639998,
year = {2021},
author = {Davanzo, R and Agosti, M and Cetin, I and Chiantera, A and Corsello, G and Ramenghi, LA and Staiano, A and Tavio, M and Villani, A and Viora, E and Mosca, F},
title = {Breastfeeding and COVID-19 vaccination: position statement of the Italian scientific societies.},
journal = {Italian journal of pediatrics},
volume = {47},
number = {1},
pages = {45},
pmid = {33639998},
issn = {1824-7288},
mesh = {*Breast Feeding ; COVID-19/*prevention & control ; *COVID-19 Vaccines ; Consensus ; Female ; Humans ; Italy ; Societies, Medical ; },
abstract = {The availability of a COVID-19 vaccine has raised the issue of its compatibility with breastfeeding. Consequently, the Italian Society of Neonatology (SIN), the Italian Society of Pediatrics (SIP), the Italian Society of Perinatal Medicine (SIMP), the Italian Society of Obstetrics and Gynecology (SIGO), the Italian Association of Hospital Obstetricians-Gynecologists (AOGOI) and the Italian Society of Infectious and Tropical Diseases (SIMIT) have made an ad hoc consensus statement. Currently, knowledge regarding the administration of COVID-19 vaccine to the breastfeeding mother is limited. Nevertheless, as health benefits of breastfeeding are well demonstrated and since biological plausibility suggests that the health risk for the nursed infant is unlikely, Italian scientific societies conclude that COVID-19 vaccination is compatible with breastfeeding.},
}

*Breast Feeding
COVID-19/*prevention & control
*COVID-19 Vaccines
Consensus
Female
Humans
Italy
Societies, Medical

@article {pmid33630471,
year = {2021},
author = {Asbun, HJ and Abu Hilal, M and Kunzler, F and Asbun, D and Bonjer, J and Conlon, K and Demartines, N and Feldman, LS and Morales-Conde, S and Pietrabissa, A and Pryor, AD and Schlachta, CM and Sylla, P and Targarona, EM and Agra, Y and Besselink, MG and Callery, M and Cleary, SP and De La Cruz, L and Eckert, P and Evans, C and Han, HS and Jones, DB and Gan, TJ and Koch, D and Lillemoe, KD and Lomanto, D and Marks, J and Matthews, B and Mellinger, J and Melvin, WS and Moreno-Paquentin, E and Navarrete, C and Pawlik, TM and Pessaux, P and Ricciardi, W and Schwaitzberg, S and Shah, P and Szokol, J and Talamini, M and Torres, R and Triboldi, A and Udomsawaengsup, S and Valsecchi, F and Vauthey, JN and Wallace, M and Wexner, SD and Zinner, M and Francis, N},
title = {International Delphi Expert Consensus on Safe Return to Surgical and Endoscopic Practice: From the Coronavirus Global Surgical Collaborative.},
journal = {Annals of surgery},
volume = {274},
number = {1},
pages = {50-56},
pmid = {33630471},
issn = {1528-1140},
mesh = {COVID-19/epidemiology/*prevention & control/transmission ; Consensus ; Delphi Technique ; *Elective Surgical Procedures ; *Endoscopy ; Humans ; Infection Control/*organization & administration ; Internationality ; Intersectoral Collaboration ; Triage ; },
abstract = {OBJECTIVE: The aim of this work is to formulate recommendations based on global expert consensus to guide the surgical community on the safe resumption of surgical and endoscopic activities.

BACKGROUND: The COVID-19 pandemic has caused marked disruptions in the delivery of surgical care worldwide. A thoughtful, structured approach to resuming surgical services is necessary as the impact of COVID-19 becomes better controlled. The Coronavirus Global Surgical Collaborative sought to formulate, through rigorous scientific methodology, consensus-based recommendations in collaboration with a multidisciplinary group of international experts and policymakers.

METHODS: Recommendations were developed following a Delphi process. Domain topics were formulated and subsequently subdivided into questions pertinent to different aspects of surgical care in the COVID-19 crisis. Forty-four experts from 15 countries across 4 continents drafted statements based on the specific questions. Anonymous Delphi voting on the statements was performed in 2 rounds, as well as in a telepresence meeting.

RESULTS: One hundred statements were formulated across 10 domains. The statements addressed terminology, impact on procedural services, patient/staff safety, managing a backlog of surgeries, methods to restart and sustain surgical services, education, and research. Eighty-three of the statements were approved during the first round of Delphi voting, and 11 during the second round. A final telepresence meeting and discussion yielded acceptance of 5 other statements.

CONCLUSIONS: The Delphi process resulted in 99 recommendations. These consensus statements provide expert guidance, based on scientific methodology, for the safe resumption of surgical activities during the COVID-19 pandemic.},
}

COVID-19/epidemiology/*prevention & control/transmission
Consensus
Delphi Technique
*Elective Surgical Procedures
*Endoscopy
Humans
Infection Control/*organization & administration
Internationality
Intersectoral Collaboration
Triage

@article {pmid33586006,
year = {2021},
author = {Kaplan, AG and Correia-de-Sousa, J and McIvor, A and , },
title = {Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age.},
journal = {Advances in therapy},
volume = {38},
number = {3},
pages = {1382-1396},
pmid = {33586006},
issn = {1865-8652},
mesh = {Adrenergic beta-Agonists/*pharmacology ; Adult ; Anti-Asthmatic Agents/pharmacology ; *Asthma/diagnosis/drug therapy ; *COVID-19/epidemiology/prevention & control ; Child ; Drug Misuse/*prevention & control ; Female ; Global Health/standards ; Guideline Adherence ; Humans ; Male ; Medication Therapy Management/*standards ; Metered Dose Inhalers ; Practice Guidelines as Topic ; Quality Improvement/*organization & administration ; SARS-CoV-2 ; },
abstract = {INTRODUCTION: Widespread misuse of short-acting beta-agonists (SABAs) may contribute to asthma-related morbidity and mortality. Recognizing this, the Global Initiative for Asthma neither recommends SABA monotherapy nor regards this formulation as a preferred reliever. Many health systems and healthcare professionals (HCPs) experience practical issues in implementing guidelines. Clear quality standards can drive improvements in asthma care and encourage implementation of global and national medical guidelines.

METHODS: A steering group of global asthma experts came together between May and September 2019 to develop quality statements codifying the minimum elements of good quality asthma care. These statements were either evidence based (when robust evidence was available) or reflected a consensus based on clinical expertise and experience of the group.

RESULTS: The quality statements (and associated essential criteria) developed emphasize key elements concerning (1) objective diagnosis specific to individual symptoms, (2) treatment appropriate to the long-term management of asthma as an inflammatory disease, consistent with evidence-based recommendations, (3) controlled dispensing of SABA canisters and monitoring to prevent overuse, (4) regular review of patients after treatment initiation or change, and (5) follow-up of patients in primary care after treatment for an exacerbation in a hospital or an emergency department.

CONCLUSIONS: The steering group proposes quality statements that national and local clinical groups can implement as quantitative quality standards that are appropriate to their local circumstances, including during the coronavirus disease 2019 (Covid-19) pandemic. By translating these statements into locally relevant quality standards, primary care physicians and HCPs can encourage optimal management and reduce preventable healthcare interactions. The evidence-based evolution of care encapsulated in these statements will further engender high-quality, patient-centered holistic management that addresses asthma as an inflammatory disease. In particular, the statements empower self-management by patients and encourage health-promoting behaviors, which are essential to reduce exacerbations, the primary goal of asthma management.},
}

Adrenergic beta-Agonists/*pharmacology
Adult
Anti-Asthmatic Agents/pharmacology
*Asthma/diagnosis/drug therapy
*COVID-19/epidemiology/prevention & control
Child
Drug Misuse/*prevention & control
Female
Global Health/standards
Guideline Adherence
Humans
Male
Medication Therapy Management/*standards
Metered Dose Inhalers
Practice Guidelines as Topic
Quality Improvement/*organization & administration
SARS-CoV-2

@article {pmid33577086,
year = {2021},
author = {Fix, OK and Blumberg, EA and Chang, KM and Chu, J and Chung, RT and Goacher, EK and Hameed, B and Kaul, DR and Kulik, LM and Kwok, RM and McGuire, BM and Mulligan, DC and Price, JC and Reau, NS and Reddy, KR and Reynolds, A and Rosen, HR and Russo, MW and Schilsky, ML and Verna, EC and Ward, JW and Fontana, RJ and , },
title = {American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.},
journal = {Hepatology (Baltimore, Md.)},
volume = {74},
number = {2},
pages = {1049-1064},
pmid = {33577086},
issn = {1527-3350},
support = {UL1 TR001863/TR/NCATS NIH HHS/United States ; },
mesh = {Adult ; COVID-19/*prevention & control ; COVID-19 Vaccines/administration & dosage/*standards ; Consensus ; Humans ; *Liver Diseases ; *Liver Transplantation ; Practice Guidelines as Topic ; SARS-CoV-2/immunology ; United States ; },
abstract = {The aim of this document is to provide a concise scientific review of the currently available COVID-19 vaccines and those in development, including mRNA, adenoviral vectors, and recombinant protein approaches. The anticipated use of COVID-19 vaccines in patients with chronic liver disease (CLD) and liver transplant (LT) recipients is reviewed and practical guidance is provided for health care providers involved in the care of patients with liver disease and LT about vaccine prioritization and administration. The Pfizer and Moderna mRNA COVID-19 vaccines are associated with a 94%-95% vaccine efficacy compared to placebo against COVID-19. Local site reactions of pain and tenderness were reported in 70%-90% of clinical trial participants, and systemic reactions of fever and fatigue were reported in 40%-70% of participants, but these reactions were generally mild and self-limited and occurred more frequently in younger persons. Severe hypersensitivity reactions related to the mRNA COVID-19 vaccines are rare and more commonly observed in women and persons with a history of previous drug reactions for unclear reasons. Because patients with advanced liver disease and immunosuppressed patients were excluded from the vaccine licensing trials, additional data regarding the safety and efficacy of COVID-19 vaccines are eagerly awaited in these and other subgroups. Remarkably safe and highly effective mRNA COVID-19 vaccines are now available for widespread use and should be given to all adult patients with CLD and LT recipients. The online companion document located at https://www.aasld.org/about-aasld/covid-19-resources will be updated as additional data become available regarding the safety and efficacy of other COVID-19 vaccines in development.},
}

Adult
COVID-19/*prevention & control
COVID-19 Vaccines/administration & dosage/*standards
Consensus
Humans
*Liver Diseases
*Liver Transplantation
Practice Guidelines as Topic
SARS-CoV-2/immunology
United States

@article {pmid33533553,
year = {2021},
author = {Beecker, J and Papp, KA and Dutz, J and Vender, RB and Gniadecki, R and Cooper, C and Gisondi, P and Gooderham, M and Hong, CH and Kirchhof, MG and Lynde, CW and Maari, C and Poulin, Y and Puig, L},
title = {Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.},
journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
volume = {35},
number = {4},
pages = {797-806},
pmid = {33533553},
issn = {1468-3083},
mesh = {COVID-19/complications/*epidemiology/therapy ; Dermatitis/*therapy ; Humans ; *Immunotherapy ; Practice Patterns, Physicians' ; Risk Assessment ; },
abstract = {Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, a novel RNA virus that was declared a global pandemic on 11 March 2020. The efficiency of infection with SARS-CoV-2 is reflected by its rapid global spread. The SARS-CoV-2 pandemic has implications for patients with inflammatory skin diseases on systemic immunotherapy who may be at increased risk of infection or more severe infection. This position paper is a focused examination of current evidence considering the mechanisms of action of immunotherapeutic drugs in relation to immune response to SARS-CoV-2. We aim to provide practical guidance for dermatologists managing patients with inflammatory skin conditions on systemic therapies during the current pandemic and beyond. Considering the limited and rapidly evolving evidence, mechanisms of action of therapies, and current knowledge of SARS-CoV-2 infection, we propose that systemic immunotherapy can be continued, with special considerations for at risk patients or those presenting with symptoms.},
}

COVID-19/complications/*epidemiology/therapy
Dermatitis/*therapy
Humans
*Immunotherapy
Practice Patterns, Physicians'
Risk Assessment

@article {pmid33518409,
year = {2021},
author = {Zimmerman, E and Martins, NN and Verheijen, RHM and Mahmood, T},
title = {EBCOG position statement - Simulation-based training for obstetrics and gynaecology during the COVID-19 pandemic.},
journal = {European journal of obstetrics, gynecology, and reproductive biology},
volume = {258},
number = {},
pages = {457-458},
pmid = {33518409},
issn = {1872-7654},
mesh = {COVID-19/epidemiology ; Curriculum ; Female ; Gynecology/*education ; Humans ; Obstetrics/*education ; Pandemics ; Pregnancy ; SARS-CoV-2 ; Simulation Training/*standards ; },
abstract = {The specialty of Obstetrics and Gynaecology has been on the forefront of introducing simulation in post graduate education for the past two decades. Simulation training is known to enhance psychomotor skills and is considered an important step in the transition from classroom learning to clinical practice. Training on simulators allows trainees to acquire basic skills before getting involved in day to day care in real life situations. Clinical circumstances around the COVID 19 pandemic have highlighted the key importance of simulation training in delivering post graduate curriculum.},
}

COVID-19/epidemiology
Curriculum
Female
Gynecology/*education
Humans
Obstetrics/*education
Pandemics
Pregnancy
SARS-CoV-2
Simulation Training/*standards

@article {pmid33495916,
year = {2021},
author = {Torres-Naranjo, F and De la Peña-Rodríguez, P and López-Cervantes, RE and Morales-Torres, J and Morales-Vargas, J and Gutiérrez-Hermosillo, H and Guzmán-Rico, AC and González-Mendoza, RG and Rueda Plata, PN and Flores Castro, M and Celis Gonzalez, C and Espinosa Morales, R and Quintero Hernández, S and López-Taylor, JR},
title = {Joint position statement on management of patient with osteoporosis during COVID-19 contingency from the AMMOM, CONAMEGER, FELAEN, FEMECOG, FEMECOT, and ICAAFYD.},
journal = {Archives of osteoporosis},
volume = {16},
number = {1},
pages = {18},
pmid = {33495916},
issn = {1862-3514},
mesh = {Aged ; *COVID-19 ; Humans ; *Medicine ; *Orthopedics ; *Osteoporosis/epidemiology/therapy ; Pandemics ; SARS-CoV-2 ; *Traumatology ; },
abstract = {UNLABELLED: Infection by SARS-Cov-2 (COVID-19) has affected practically all the world. This joint position statement of Latin American Medical Societies provides an updated guide for the prevention, diagnosis, and treatment of osteoporotic patients in the face of possible clinical scenarios posed by the COVID-19 health crisis.

BACKGROUND: Infection by SARS-Cov-2 (COVID-19) has affected practically all the world. Characterized by high contagiousness, significative morbidity, and mortality in a segment of those infected, it has overwhelmed health services and forced to redirect resources to the emergency while impacting the attention of acute non-COVID-19 and many chronic conditions.

OBJECTIVE: The objective of this study is to provide an updated guide for the prevention, diagnosis, and treatment of osteoporotic patients in the face of possible clinical scenarios posed by the COVID-19 health crisis.

METHODS: A task force, of bone specialists with a wide range of disciplines in the field of osteoporosis and fragility fracture, was convened with the representation of several professional associations, namely, the Mexican Association of Bone and Mineral Metabolism (AMMOM), the National College of Geriatric Medicine (CONAMEGER), the Latin American Federation of Endocrinology (FELAEN), the Mexican Federation of Colleges of Obstetrics and Gynecology (FEMECOG), the Mexican Federation of Colleges of Orthopedics and Traumatology (FEMECOT), and the Institute of Applied Sciences for Physical Activity and Sports of the University of Guadalajara (ICAAFYD). Clinical evidence was collated, and an evidence report was rapidly generated and disseminated. After finding the gaps in the available evidence, a consensus opinion of experts was made. The resulting draft was reviewed and modified accordingly, in 4 rounds, by the participants.

RESULTS: The task force approved the initial guidance statements, with moderate and high consensus. These were combined, resulting in the final guidance statements on the (1) evaluation of fracture risk; (2) stratification of risk priorities; (3) indications of bone density scans and lab tests; (4) initiation and continuation of pharmacologic therapy; (5) interruptions of therapy; (6) treatment of patients with incident fracture; (7) physical therapy and fall prevention; and (8) nutritional interventions.

CONCLUSION: These guidance statements are provided to promote optimal care to patients at risk for osteoporosis and fracture, during the current COVID-19 pandemic. However, given the low level of available evidence and the rapidly evolving literature, this guidance is presented as a "living document" and future updates are anticipated.},
}

Aged
*COVID-19
Humans
*Medicine
*Orthopedics
*Osteoporosis/epidemiology/therapy
Pandemics
SARS-CoV-2
*Traumatology

@article {pmid33484264,
year = {2021},
author = {Ma, B and Fan, X and Kong, W and Xiao, S and Zhu, S and Yao, M and Liu, Y and Zhu, W and Wang, J and Zeng, Y and Zhao, Y and Su, B and Xu, S and Dong, Z and Gu, H and Li, W and Jiang, Y and Gu, D and Xia, Z},
title = {Expert Consensus on Clinical Practice of Burn Units in Shanghai During the COVID-19 Epidemic.},
journal = {Journal of burn care & research : official publication of the American Burn Association},
volume = {42},
number = {4},
pages = {642-645},
doi = {10.1093/jbcr/irab010},
pmid = {33484264},
issn = {1559-0488},
support = {81930057//National Natural Science Foundation of China/ ; 2019-I2M-5-076//CAMS Innovation Fund for Medical Sciences/ ; },
mesh = {Burn Units/*organization & administration ; Burns/epidemiology/*therapy ; COVID-19/*epidemiology/therapy ; China/epidemiology ; *Consensus ; Critical Care/*organization & administration ; Humans ; Infection Control/organization & administration ; },
abstract = {In response to coronavirus disease 2019 (COVID-19), the Shanghai Burn Clinical Quality Control Center organized experts to formulate and implement a set of rapid, simple, and effective prevention and control measures, and there have not been any cases of health care professionals or inpatients in burn units suspected or confirmed with COVID-19. This article elaborates on the specific measures in burn units in response to the epidemic, including the implementation of standardized procedures, remote consultations, strengthened follow-up, exchange of experience, and popular science, among others. We share experience from Shanghai to benefit related disciplines in other countries and regions.},
}

Burn Units/*organization & administration
Burns/epidemiology/*therapy
COVID-19/*epidemiology/therapy
China/epidemiology
*Consensus
Critical Care/*organization & administration
Humans
Infection Control/organization & administration

@article {pmid33472895,
year = {2021},
author = {Siegel, CA and Melmed, GY and McGovern, DP and Rai, V and Krammer, F and Rubin, DT and Abreu, MT and Dubinsky, MC and , and , },
title = {SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.},
journal = {Gut},
volume = {70},
number = {4},
pages = {635-640},
pmid = {33472895},
issn = {1468-3288},
support = {P30 DK042086/DK/NIDDK NIH HHS/United States ; },
mesh = {Anti-Inflammatory Agents/immunology/pharmacology ; *COVID-19/epidemiology/immunology/prevention & control ; *COVID-19 Vaccines/classification/immunology/therapeutic use ; Consensus ; Gastroenterology/methods/standards ; Humans ; Immunogenicity, Vaccine/drug effects/immunology ; Immunomodulation/drug effects/immunology ; *Inflammatory Bowel Diseases/drug therapy/immunology ; International Cooperation ; SARS-CoV-2 ; *Vaccination/methods/standards ; },
}

Anti-Inflammatory Agents/immunology/pharmacology
*COVID-19/epidemiology/immunology/prevention & control
*COVID-19 Vaccines/classification/immunology/therapeutic use
Consensus
Gastroenterology/methods/standards
Humans
Immunogenicity, Vaccine/drug effects/immunology
Immunomodulation/drug effects/immunology
*Inflammatory Bowel Diseases/drug therapy/immunology
International Cooperation
SARS-CoV-2
*Vaccination/methods/standards

@article {pmid33419600,
year = {2021},
author = {White, SJ and Barello, S and Cao di San Marco, E and Colombo, C and Eeckman, E and Gilligan, C and Graffigna, G and Jirasevijinda, T and Mosconi, P and Mullan, J and Rehman, SU and Rubinelli, S and Vegni, E and Krystallidou, D},
title = {Critical observations on and suggested ways forward for healthcare communication during COVID-19: pEACH position paper.},
journal = {Patient education and counseling},
volume = {104},
number = {2},
pages = {217-222},
pmid = {33419600},
issn = {1873-5134},
mesh = {*COVID-19 ; *Health Communication ; Health Literacy ; Health Personnel/*psychology ; Health Promotion/*methods ; Humans ; Pandemics ; *Public Health Practice ; *SARS-CoV-2 ; *Telemedicine ; Uncertainty ; },
abstract = {OBJECTIVE: Communication in healthcare has influenced and been influenced by the COVID-19 pandemic. In this position paper, we share observations based on the latest available evidence and experiential knowledge that have emerged during the pandemic, with a specific focus on policy and practice.

METHODS: This is a position paper that presents observations relating to policy and practice in communication in healthcare related to COVID-19.

RESULTS: Through our critical observations as experts in the field of healthcare communication, we share our stance how healthcare communication has occured during the pandemic and suggest possible ways of improving policy and professional practice. We make recommendations for policy makers, healthcare providers, and communication experts while also highlighting areas that merit further investigation regarding healthcare communication in times of healthcare crises.

CONCLUSION: We have witnessed an upheaval of healthcare practice and the development of policy on-the-run. To ensure that policy and practice are evidence-based, person-centred, more inclusive and equitable, we advocate for critical reflection on this symbiotic relationship between COVID-19 and the central role of communication in healthcare.

PRACTICE IMPLICATIONS: This paper provides a summary of the key areas for development in communication in healthcare during COVID-19. It offers recommendations for improvement and a call to review policies and practice to build resilience and inclusive and equitable responsiveness in communication in healthcare.},
}

*COVID-19
*Health Communication
Health Literacy
Health Personnel/*psychology
Health Promotion/*methods
Humans
Pandemics
*Public Health Practice
*SARS-CoV-2
*Telemedicine
Uncertainty

@article {pmid33416050,
year = {2021},
author = {Chieffo, A and Tarantini, G and Naber, CK and Barbato, E and Roffi, M and Stefanini, GG and Buchanan, GL and Buszman, P and Moreno, R and Zawiślak, B and Cayla, G and Danenberg, H and Da Silveira, JAB and Nef, H and James, SK and Mauri Ferre, J and Voskuil, M and Witt, N and Windecker, S and Baumbach, A and Dudek, D},
title = {Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI).},
journal = {EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
volume = {16},
number = {14},
pages = {1177-1186},
pmid = {33416050},
issn = {1969-6213},
mesh = {*COVID-19 ; *Cardiovascular Surgical Procedures ; *Elective Surgical Procedures ; Humans ; Masks ; *Pandemics ; Personal Protective Equipment ; SARS-CoV-2 ; },
abstract = {The rearrangement of healthcare services required to face the coronavirus disease 2019 (COVID-19) pandemic led to a drastic reduction in elective cardiac invasive procedures. We are already facing a "second wave" of infections and we might be dealing during the next months with a "third wave" and subsequently new waves. Therefore, during the different waves of the COVID-19 pandemic we have to face the problems of how to perform elective cardiac invasive procedures in non-COVID patients and which patients/procedures should be prioritised. In this context, the interplay between the pandemic stage, the availability of healthcare resources and the priority of specific cardiac disorders is crucial. Clear pathways for "hot" or presumed "hot" patients and "cold" patients are mandatory in each hospital. Depending on the local testing capacity and intensity of transmission in the area, healthcare facilities may test patients for SARS-CoV-2 infection before the interventional procedure, regardless of risk assessment for COVID-19. Pre-hospital testing should always be conducted in the presence of symptoms suggestive of SARS-CoV-2 infection. In cases of confirmed or suspected COVID-19 positive patients, full personal protective equipment using FFP 2/N95 masks, eye protection, gowning and gloves is indicated during cardiac interventions for healthcare workers. When patients have tested negative for COVID-19, medical masks may be sufficient. Indeed, individual patients should themselves wear medical masks during cardiac interventions and outpatient visits.},
}

*COVID-19
*Cardiovascular Surgical Procedures
*Elective Surgical Procedures
Humans
Masks
*Pandemics
Personal Protective Equipment
SARS-CoV-2

@article {pmid33414261,
year = {2021},
author = {Wu, F and Burt, J and Chowdhury, T and Fitzpatrick, R and Martin, G and van der Scheer, JW and Hurst, JR},
title = {Specialty COPD care during COVID-19: patient and clinician perspectives on remote delivery.},
journal = {BMJ open respiratory research},
volume = {8},
number = {1},
pages = {},
pmid = {33414261},
issn = {2052-4439},
mesh = {Adult ; Aged ; *Attitude of Health Personnel ; Attitude to Health ; COVID-19 ; Delivery of Health Care/methods ; Female ; Humans ; Male ; Middle Aged ; Nurses ; Patient Acceptance of Health Care ; *Patient Education as Topic ; Physical Therapists ; Physicians ; Practice Patterns, Nurses' ; *Practice Patterns, Physicians' ; Pulmonary Disease, Chronic Obstructive/physiopathology/*therapy ; SARS-CoV-2 ; *Self-Management ; Severity of Illness Index ; *Smoking Cessation ; Surveys and Questionnaires ; Telemedicine/*methods ; United Kingdom ; },
abstract = {INTRODUCTION: The COVID-19 pandemic has impacted specialty chronic obstructive pulmonary disease (COPD) care. We examined the degree to which care has moved to remote approaches, eliciting clinician and patient perspectives on what is appropriate for ongoing remote delivery.

METHODS: Using an online research platform, we conducted a survey and consensus-building process involving clinicians and patients with COPD.

RESULTS: Fifty-five clinicians and 19 patients responded. The majority of clinicians felt able to assess symptom severity (n=52, 95%), reinforce smoking cessation (n=46, 84%) and signpost to other healthcare resources (n=44, 80%). Patients reported that assessing COPD severity and starting new medications were being addressed through remote care. Forty-three and 31 respondents participated in the first and second consensus-building rounds, respectively. When asked to rate the appropriateness of using remote delivery for specific care activities, respondents reached consensus on 5 of 14 items: collecting information about COPD and overall health status (77%), providing COPD education and developing a self-management plan (74%), reinforcing smoking cessation (81%), deciding whether patients should seek in-person care (72%) and initiating a rescue pack (76%).

CONCLUSION: Adoption of remote care delivery appears high, with many care activities partially or completely delivered remotely. Our work identifies strengths and limitations of remote care delivery.},
}

Adult
Aged
*Attitude of Health Personnel
Attitude to Health
COVID-19
Delivery of Health Care/methods
Female
Humans
Male
Middle Aged
Nurses
Patient Acceptance of Health Care
*Patient Education as Topic
Physical Therapists
Physicians
Practice Patterns, Nurses'
*Practice Patterns, Physicians'
Pulmonary Disease, Chronic Obstructive/physiopathology/*therapy
SARS-CoV-2
*Self-Management
Severity of Illness Index
*Smoking Cessation
Surveys and Questionnaires
Telemedicine/*methods
United Kingdom

@article {pmid33412794,
year = {2020},
author = {Ciccone, G and Deandrea, S and Clavenna, A and Kirchmayer, U and Simeon, V and Acampora, A and Agabiti, N and Angelici, L and Banzi, R and Cadum, E and Castiglione, A and Chiodini, P and Colombo, C and Ferroni, E and Migliore, E and Nisticò, L and Pagano, E and Sabelli, AM and Sacerdote, C and Silvestri, C and Soldati, S and Stranges, S and Tirani, M and Davoli, M and Galassi, C and Forastiere, F},
title = {[Covid-19 and clinical-epidemiological research in Italy: proposal of a research agenda on priority topics by the Italian association of epidemiology].},
journal = {Epidemiologia e prevenzione},
volume = {44},
number = {5-6 Suppl 2},
pages = {51-59},
doi = {10.19191/EP20.5-6.S2.103},
pmid = {33412794},
issn = {1120-9763},
mesh = {Adult ; Aged ; COVID-19/*epidemiology/therapy ; Child ; *Epidemiologic Research Design ; Epidemiology/organization & administration ; Female ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; *Pandemics ; Pregnancy ; Pregnancy Complications, Infectious/epidemiology ; Prognosis ; *Research ; *SARS-CoV-2 ; Societies, Scientific ; Therapeutic Equipoise ; COVID-19 Drug Treatment ; },
abstract = {BACKGROUND: the Covid-19 pandemic has provoked a huge of clinical and epidemiological research initiatives, especially in the most involved countries. However, this very large effort was characterized by several methodological weaknesses, both in the field of discovering effective treatments (with too many small and uncontrolled trials) and in the field of identifying preventable risks and prognostic factors (with too few large, representative and well-designed cohorts or case-control studies).

OBJECTIVES: in response to the fragmented and uncoordinated research production on Covid-19, the   italian Association of Epidemiology (AIE) stimulated the formation of a working group (WG) with the aims of identifying the most important gaps in knowledge and to propose a structured research agenda of clinical and epidemiological studies considered at high priority on Covid-19, including recommendations on the preferable methodology.

METHODS: the WG was composed by 25 subjects, mainly epidemiologists, statisticians, and other experts in specific fields, who have voluntarily agreed to the proposal. The agreement on a list of main research questions and on the structure of the specific documents to be produced were defined through few meetings and cycles of document exchanges.

RESULTS: twelve main research questions on Covid-19 were identified, covering aetiology, prognosis, interventions, follow-up and impact on general and specific populations (children, pregnant women). For each of them, a two-page form was developed, structured in: background, main topics, methods (with recommendations on preferred study design and warnings for bias prevention) and an essential bibliography.

CONCLUSIONS: this research agenda represents an initial contribution to direct clinical and epidemiological research efforts on high priority topics with a focus on methodological aspects. Further development and refinements of this agenda by Public Health Authorities are encouraged.},
}

Adult
Aged
COVID-19/*epidemiology/therapy
Child
*Epidemiologic Research Design
Epidemiology/organization & administration
Female
Humans
Italy/epidemiology
Male
Middle Aged
*Pandemics
Pregnancy
Pregnancy Complications, Infectious/epidemiology
Prognosis
*Research
*SARS-CoV-2
Societies, Scientific
Therapeutic Equipoise
COVID-19 Drug Treatment

@article {pmid33394078,
year = {2021},
author = {Lan, X and Long, Y and Shao, F and Song, Y},
title = {Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version).},
journal = {European journal of nuclear medicine and molecular imaging},
volume = {48},
number = {4},
pages = {1134-1143},
pmid = {33394078},
issn = {1619-7089},
mesh = {COVID-19/*prevention & control ; China/epidemiology ; Consensus ; Disease Outbreaks/*prevention & control ; Humans ; Nuclear Medicine/*trends ; SARS-CoV-2 ; },
abstract = {In December 2019, an infectious disease caused by a new type of coronavirus infection was prevalent in Wuhan and across the country. On January 20, 2020, the National Health Commission of the People's Republic of China issued No.1 Announcement, which incorporated the novel coronavirus pneumonia into the Class B infectious disease according to the Law on Prevention and Control of Infectious Disease, but the disease should be adopted in the management of Class A infectious disease. In order to effectively control the source of infection, cut off the transmission route, protect the susceptible population, ensure the medical quality and medical safety, perform epidemic prevention and control, and comprehensively guarantee the life safety and physical health of medical staff, patients, and family members, it is very important to organize and carry out nuclear medicine diagnosis and treatment scientifically and safely. According to the national prevention and control policy, Chinese Society of Nuclear Medicine and editorial board of the Chinese Journal of Nuclear Medicine and Molecular Imaging organized professionals to formulate the expert consensus on the safety prevention process of nuclear medicine imaging and nuclide therapy during the period of new coronavirus infection.},
}

COVID-19/*prevention & control
China/epidemiology
Consensus
Disease Outbreaks/*prevention & control
Humans
Nuclear Medicine/*trends
SARS-CoV-2

@article {pmid33378789,
year = {2021},
author = {Klimek, L and Jutel, M and Akdis, CA and Bousquet, J and Akdis, M and Torres, MJ and Agache, I and Canonica, GW and Del Giacco, S and O'Mahony, L and Shamji, MH and Schwarze, J and Untersmayr, E and Ring, J and Bedbrook, A and Worm, M and Zuberbier, T and Knol, E and Hoffmann-Sommergruber, K and Chivato, T},
title = {ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.},
journal = {Allergy},
volume = {76},
number = {6},
pages = {1624-1628},
doi = {10.1111/all.14726},
pmid = {33378789},
issn = {1398-9995},
mesh = {BNT162 Vaccine ; *COVID-19 ; COVID-19 Vaccines ; Humans ; SARS-CoV-2 ; *Vaccines/adverse effects ; },
abstract = {Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT162b2, several severe anaphylaxis cases occured within the first few days of public vaccination. An investigation is taking place to understand the cases and their triggers. The vaccine will be administered to a large number of individuals worldwide and there are raising concerns that severe adverse events might occur. With the current information, the European Academy of Allergy and Clinical Immunology (EAACI) states its position for the following preliminary recommendations that are to be revised as soon as more data emerge. To minimize the risk of severe allergic reactions in vaccinated individuals, it is urgently required to understand the specific nature of the reported severe allergic reactions, including the background medical history of the individuals affected and the mechanisms involved. To achieve this goal, all clinical and laboratory information should be collected and reported. Mild and moderate allergic patients should not be excluded from the vaccine as this could have a significant impact on reaching the goal of population immunity. Healthcare practitioners vaccinating against COVID-19 are required to be sufficiently prepared to recognize and treat anaphylaxis properly with the ability to administer adrenaline. Further to vaccine administration, a mandatory observation period of at least 15 minutes should be followed for all individuals. The current data have not shown any higher risk for patients suffering from allergic rhinitis or asthma, and this message should be clearly stated by physicians to enable our patients to trust the vaccine. More than 30% of the population suffers from allergic diseases and the benefit of the vaccination clearly outweighs the risk of severe COVID-19 development.},
}

BNT162 Vaccine
*COVID-19
COVID-19 Vaccines
Humans
SARS-CoV-2
*Vaccines/adverse effects

@article {pmid33372938,
year = {2020},
author = {Corona, T and Castañón-González, JA and Clark-Peralta, P and García-Peña, C and Guevara-Guzmán, R and Domínguez-Cherit, G and Halabe-Cherem, J and López-Cervantes, M and Macias-Hernández, A and Rodríguez-Violante, M and Santillán-Doherty, P and Anda, GV and Guinzberg, AL},
title = {Position paper: Impact on medical and health personnel in the SARS-CoV-2 pandemic.},
journal = {Gaceta medica de Mexico},
volume = {156},
number = {5},
pages = {478-480},
doi = {10.24875/GMM.M20000432},
pmid = {33372938},
issn = {0016-3813},
mesh = {COVID-19/*prevention & control/*transmission ; *Health Personnel ; Humans ; Infectious Disease Transmission, Patient-to-Professional/*prevention & control ; Practice Guidelines as Topic ; },
}

COVID-19/*prevention & control/*transmission
*Health Personnel
Humans
Infectious Disease Transmission, Patient-to-Professional/*prevention & control
Practice Guidelines as Topic

@article {pmid33359375,
year = {2021},
author = {Mussini, C and Falcone, M and Nozza, S and Sagnelli, C and Parrella, R and Meschiari, M and Petrosillo, N and Mastroianni, C and Cascio, A and Iaria, C and Galli, M and Chirianni, A and Sagnelli, E and Iacobello, C and Di Perri, G and Mazzotta, F and Carosi, G and Tinelli, M and Grossi, P and Armignacco, O and Portelli, V and Andreoni, M and Tavio, M and , },
title = {Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT).},
journal = {Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
volume = {27},
number = {3},
pages = {389-395},
pmid = {33359375},
issn = {1469-0691},
mesh = {COVID-19/diagnosis/epidemiology/therapy ; Humans ; Italy/epidemiology ; *Practice Guidelines as Topic ; Randomized Controlled Trials as Topic ; SARS-CoV-2/isolation & purification ; Societies, Medical/*standards ; Standard of Care ; *COVID-19 Drug Treatment ; },
abstract = {SCOPE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become pandemic, reaching almost one million death worldwide. At present standard treatment for coronavirus disease 2019 (COVID-19) is not well defined because the evidence, either from randomized or observational studies, with conflicting results, has led to rapid changes in treatment guidelines. Our aim was to narratively summarize the available literature on the management of COVID-19 in order to combine current evidence and interpretation of the data by experts who are treating patients in the frontline setting.

METHODS: The panel conducted a detailed review of the literature and eventual press releases from randomized clinical trials for each possible available treatment. Inductive PubMed search waws performed for publications relevant to the topic, including all clinical trials conducted. The result was a flowchart with treatment indications for patients with COVID-19.

IMPLICATIONS: After 6 months of a pandemic situation and before a possible second coronavirus wave descends on Europe, it is important to evaluate which drugs proved to be effective while also considering that results from many randomized clinical trials are still awaited. Indeed, among treatments for COVID-19, only glucocorticoids have resulted in an association with a significant decrease in mortality in published randomized controlled trials. New therapeutic strategies are urgently needed.},
}

COVID-19/diagnosis/epidemiology/therapy
Humans
Italy/epidemiology
*Practice Guidelines as Topic
Randomized Controlled Trials as Topic
SARS-CoV-2/isolation & purification
Societies, Medical/*standards
Standard of Care
*COVID-19 Drug Treatment

@article {pmid33350389,
year = {2021},
author = {Annweiler, C and Souberbielle, JC},
title = {[Vitamin D supplementation and COVID-19: expert consensus and guidelines].},
journal = {Geriatrie et psychologie neuropsychiatrie du vieillissement},
volume = {19},
number = {1},
pages = {20-29},
doi = {10.1684/pnv.2020.0907},
pmid = {33350389},
issn = {2115-7863},
mesh = {Adult ; COVID-19/mortality ; Dietary Supplements ; France ; Humans ; Randomized Controlled Trials as Topic ; Risk Factors ; Survival Rate ; Vitamin D/*therapeutic use ; Vitamin D Deficiency/complications/drug therapy ; *COVID-19 Drug Treatment ; },
abstract = {After 12 months of viral circulation, the SARS-CoV-2 has infected millions of people around the world, leaving hundreds of thousands dead. With the lack of effective therapy and vaccination against COVID-19, focusing on the immediate repurposing of existing drugs gives hope of curbing the pandemic. Vitamin D is a possible candidate discussed in a high amount of publications. Randomized clinical trials show that vitamin D supplementation significantly reduces the risk of respiratory infections. There are also many evidences that hypovitaminosis D is an independent (and easily modifiable) risk factor for severe forms of COVID-19 and death. Vitamin D supplementation is a simple, safe and inexpensive measure, which is effective in correcting hypovitaminosis D found in 40-50% of the French population and in more than 80% of adults with COVID-19. In this position paper, we propose simple regimens (adapted to the pharmaceutical forms currently available in France) for vitamin D supplementation in adults with or without COVID-19.},
}

Adult
COVID-19/mortality
Dietary Supplements
France
Humans
Randomized Controlled Trials as Topic
Risk Factors
Survival Rate
Vitamin D/*therapeutic use
Vitamin D Deficiency/complications/drug therapy
*COVID-19 Drug Treatment

@article {pmid33323819,
year = {2020},
author = {Sun, TW and Zhang, XJ and Yu, Z and Shang, Y},
title = {Chinese expert consensus on the diagnosis and treatment of severely and critically ill patients with coronavirus disease 2019.},
journal = {Chinese medical journal},
volume = {133},
number = {24},
pages = {2963-2965},
pmid = {33323819},
issn = {2542-5641},
mesh = {COVID-19/diagnosis/*therapy ; Consensus ; Critical Illness ; Humans ; *SARS-CoV-2 ; },
}

COVID-19/diagnosis/*therapy
Consensus
Critical Illness
Humans
*SARS-CoV-2

@article {pmid33313664,
year = {2021},
author = {Diller, GP and Gatzoulis, MA and Broberg, CS and Aboulhosn, J and Brida, M and Schwerzmann, M and Chessa, M and Kovacs, AH and Roos-Hesselink, J},
title = {Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease.},
journal = {European heart journal},
volume = {42},
number = {19},
pages = {1858-1865},
pmid = {33313664},
issn = {1522-9645},
mesh = {Adult ; *COVID-19 ; *Cardiovascular Diseases ; *Heart Defects, Congenital/complications/epidemiology/therapy ; Humans ; Pandemics ; SARS-CoV-2 ; },
abstract = {We are witnessing an unparalleled pandemic caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated with coronavirus disease 2019 (COVID-19). Current data show that SARS-CoV-2 results in mild flu-like symptoms in the majority of healthy and young patients affected. Nevertheless, the severity of COVID-19 respiratory syndrome and the risk of adverse or catastrophic outcomes are increased in patients with pre-existing cardiovascular disease. Patients with adult congenital heart disease (ACHD)-by definition-have underlying cardiovascular disease. Many patients with ACHD are also afflicted with residual haemodynamic lesions such as valve dysfunction, diminished ventricular function, arrhythmias or cyanosis, have extracardiac comorbidities, and face additional challenges regarding pregnancy. Currently, there are emerging data of the effect of COVID-19 on ACHD patients, but many aspects, especially risk stratification and treatment considerations, remain unclear. In this article, we aim to discuss the broad impact of COVID-19 on ACHD patients, focusing specifically on pathophysiology, risk stratification for work, self-isolation, hospitalization, impact on pregnancy, psychosocial health, and longer-term implications for the provision of ACHD care.},
}

Adult
*COVID-19
*Cardiovascular Diseases
*Heart Defects, Congenital/complications/epidemiology/therapy
Humans
Pandemics
SARS-CoV-2

@article {pmid33307733,
year = {2020},
author = {Nadershah, M and Al-Sebaei, M and AlJabbab, A and AlMajid, E and AlShadwi, A},
title = {Consensus Statement of the Saudi Society of Oral and Maxillofacial Surgery on practice during the COVID-19 pandemic in Saudi Arabia.},
journal = {Annals of Saudi medicine},
volume = {40},
number = {6},
pages = {491-495},
pmid = {33307733},
issn = {0975-4466},
mesh = {*COVID-19/epidemiology/prevention & control ; Consensus ; *Delivery of Health Care/organization & administration/trends ; Humans ; *Infection Control/methods/organization & administration ; Organizational Innovation ; SARS-CoV-2 ; Saudi Arabia/epidemiology ; *Societies, Medical ; *Surgery, Oral/methods/trends ; Triage/methods ; },
abstract = {The coronavirus pandemic (COVID-19) has impacted essentially every country's healthcare system in extraordinary ways, fundamentally changing the way we deliver care. The practice of oral and maxillofacial surgery is no exception. In response to this global health crisis, the Saudi Society of Oral and Maxillofacial Surgery has prepared this consensus statement to inform our clinical and other medical colleagues and the public at large on proper procedures during this time. The statement is based on the best scientific evidence available and follows the guidelines put forth by the Saudi Ministry of Health on the COVID-19 response. It explains how to manage and triage oral and maxillofacial patients based on the level of care needed at the time of clinical presentation.},
}

*COVID-19/epidemiology/prevention & control
Consensus
*Delivery of Health Care/organization & administration/trends
Humans
*Infection Control/methods/organization & administration
Organizational Innovation
SARS-CoV-2
Saudi Arabia/epidemiology
*Societies, Medical
*Surgery, Oral/methods/trends
Triage/methods

@article {pmid33295471,
year = {2020},
author = {Marques-Santos, C and Avila, WS and Carvalho, RCM and Lucena, AJG and Freire, CMV and Alexandre, ERG and Campanharo, FF and Rivera, MAMR and Costa, MENC and Castro, ML},
title = {Position Statement on COVID-19 and Pregnancy in Women with Heart Disease Department of Women Cardiology of the Brazilian Society of Cardiology - 2020.},
journal = {Arquivos brasileiros de cardiologia},
volume = {115},
number = {5},
pages = {975-986},
pmid = {33295471},
issn = {1678-4170},
mesh = {Brazil ; *COVID-19 ; *Cardiology ; Female ; *Heart Diseases ; Humans ; Pandemics ; Practice Guidelines as Topic ; Pregnancy ; *Pregnancy Complications, Neoplastic ; SARS-CoV-2 ; Societies, Medical ; },
}

Brazil
*COVID-19
*Cardiology
Female
*Heart Diseases
Humans
Pandemics
Practice Guidelines as Topic
Pregnancy
*Pregnancy Complications, Neoplastic
SARS-CoV-2
Societies, Medical

@article {pmid33274782,
year = {2021},
author = {Ma, IWY and Hussain, A and Wagner, M and Walker, B and Chee, A and Arishenkoff, S and Buchanan, B and Liu, RB and Mints, G and Wong, T and Noble, V and Tonelli, AC and Dumoulin, E and Miller, DJ and Hergott, CA and Liteplo, AS},
title = {Canadian Internal Medicine Ultrasound (CIMUS) Expert Consensus Statement on the Use of Lung Ultrasound for the Assessment of Medical Inpatients With Known or Suspected Coronavirus Disease 2019.},
journal = {Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine},
volume = {40},
number = {9},
pages = {1879-1892},
pmid = {33274782},
issn = {1550-9613},
mesh = {*COVID-19 ; Canada ; Consensus ; Humans ; *Inpatients ; Lung/diagnostic imaging ; SARS-CoV-2 ; },
abstract = {OBJECTIVES: To develop a consensus statement on the use of lung ultrasound (LUS) in the assessment of symptomatic general medical inpatients with known or suspected coronavirus disease 2019 (COVID-19).

METHODS: Our LUS expert panel consisted of 14 multidisciplinary international experts. Experts voted in 3 rounds on the strength of 26 recommendations as "strong," "weak," or "do not recommend." For recommendations that reached consensus for do not recommend, a fourth round was conducted to determine the strength of those recommendations, with 2 additional recommendations considered.

RESULTS: Of the 26 recommendations, experts reached consensus on 6 in the first round, 13 in the second, and 7 in the third. Four recommendations were removed because of redundancy. In the fourth round, experts considered 4 recommendations that reached consensus for do not recommend and 2 additional scenarios; consensus was reached for 4 of these. Our final recommendations consist of 24 consensus statements; for 2 of these, the strength of the recommendations did not reach consensus.

CONCLUSIONS: In symptomatic medical inpatients with known or suspected COVID-19, we recommend the use of LUS to: (1) support the diagnosis of pneumonitis but not diagnose COVID-19, (2) rule out concerning ultrasound features, (3) monitor patients with a change in the clinical status, and (4) avoid unnecessary additional imaging for patients whose pretest probability of an alternative or superimposed diagnosis is low. We do not recommend the use of LUS to guide admission and discharge decisions. We do not recommend routine serial LUS in patients without a change in their clinical condition.},
}

*COVID-19
Canada
Consensus
Humans
*Inpatients
Lung/diagnostic imaging
SARS-CoV-2

@article {pmid33256990,
year = {2021},
author = {Wei, H and Jiang, B and Behringer, EC and Hofmeyr, R and Myatra, SN and Wong, DT and Sullivan, EPO and Hagberg, CA and McGuire, B and Baker, PA and Li, J and Pylypenko, M and Ma, W and Zuo, M and Senturk, NM and Klein, U},
title = {Controversies in airway management of COVID-19 patients: updated information and international expert consensus recommendations.},
journal = {British journal of anaesthesia},
volume = {126},
number = {2},
pages = {361-366},
pmid = {33256990},
issn = {1471-6771},
support = {R01 AG061447/AG/NIA NIH HHS/United States ; },
mesh = {COVID-19/*transmission ; Consensus ; *Exhalation ; Humans ; Infectious Disease Transmission, Patient-to-Professional/*prevention & control ; International Cooperation ; *Personal Protective Equipment ; Practice Guidelines as Topic/*standards ; SARS-CoV-2 ; },
}

COVID-19/*transmission
Consensus
*Exhalation
Humans
Infectious Disease Transmission, Patient-to-Professional/*prevention & control
International Cooperation
*Personal Protective Equipment
Practice Guidelines as Topic/*standards
SARS-CoV-2

@article {pmid33247653,
year = {2020},
author = {Swaminathan, N and Jiandani, M and Surendran, PJ and Jacob, P and Bhise, A and Baxi, G and Devani, P and Agarwal, B and Kumar, VS and Pinto, NM and Damke, U and Prabhudesai, P},
title = {Beyond COVID-19: Evidence-Based Consensus Statement on the Role of Physiotherapy in Pulmonary Rehabilitation in the Indian Context.},
journal = {The Journal of the Association of Physicians of India},
volume = {68},
number = {12},
pages = {82-89},
pmid = {33247653},
issn = {0004-5772},
mesh = {Betacoronavirus ; COVID-19 ; Consensus ; *Coronavirus Infections ; Humans ; India ; *Pandemics ; *Physical Therapy Modalities ; *Pneumonia, Viral ; Practice Guidelines as Topic ; *Quality of Life ; *Respiratory Therapy ; SARS-CoV-2 ; },
abstract = {Post COVID-19 sequelae includes breathlessness, weakness, fatigue, decreased exercise tolerance and impaired quality of life. Physiotherapy based rehabilitation program is an essential component for post COVID-19 patients in facilitating maximum functional recovery. Expert consensus statements are available from the developed countries. There is a need for a guidelines to manage post COVID-19 sequelae in Indian context. The objective of this consensus statement is to provide evidence informed guidelines for post COVID-19 physiotherapy management as a component of pulmonary rehabilitation. This consensus statement was developed by expert panel across India. Published literatures were appraised and used to prepare the recommendations. This is the first of its kind of work providing preliminary guidelines for post COVID-19 physiotherapy.},
}

Betacoronavirus
COVID-19
Consensus
*Coronavirus Infections
Humans
India
*Pandemics
*Physical Therapy Modalities
*Pneumonia, Viral
Practice Guidelines as Topic
*Quality of Life
*Respiratory Therapy
SARS-CoV-2

@article {pmid33236964,
year = {2021},
author = {Galpin, K and Sikka, N and King, SL and Horvath, KA and Shipman, SA and , },
title = {Expert Consensus: Telehealth Skills for Health Care Professionals.},
journal = {Telemedicine journal and e-health : the official journal of the American Telemedicine Association},
volume = {27},
number = {7},
pages = {820-824},
doi = {10.1089/tmj.2020.0420},
pmid = {33236964},
issn = {1556-3669},
mesh = {*COVID-19 ; Health Personnel ; Humans ; Pandemics ; SARS-CoV-2 ; *Telemedicine ; },
abstract = {Background: The COVID-19 pandemic has driven most clinicians, from those practicing in small independent practices to those in large system, to adopt virtual care. However, individuals and organizations may lack the experience and skills that would be considered fundamental prerequisites to adopting telehealth in less urgent times. What are those skills? Before the pandemic, the Association of American Medical Colleges (AAMC) convened national experts to identify and articulate a consensus set of critical telehealth skills for clinicians. Methods: Through a structured review of the literature, followed by several rounds of review and refinement by committee and community members via a modified Delphi process, the committee came to consensus on a set of skills required by clinicians to provide quality care via telehealth. Conclusion: The consensus set of telehealth skills presented in this paper, developed by the AAMC and national experts, can serve providers and health systems seeking to ensure that clinicians are prepared to meet the demand for care delivered via telehealth now and in the future.},
}

*COVID-19
Health Personnel
Humans
Pandemics
SARS-CoV-2
*Telemedicine

@article {pmid33232832,
year = {2021},
author = {Ferreira, CE and Bonvehi, PE and de la Torre, JCG and Sáenz-Flor, KV and Condino-Neto, A},
title = {Algorithms for testing COVID-19 focused on use of RT-PCR and high-affinity serological testing: A consensus statement from a panel of Latin American experts.},
journal = {International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
volume = {103},
number = {},
pages = {260-267},
pmid = {33232832},
issn = {1878-3511},
mesh = {Algorithms ; Antibodies, Viral/*blood ; COVID-19/*diagnosis ; COVID-19 Testing/*methods ; Consensus ; Humans ; Reverse Transcriptase Polymerase Chain Reaction/*methods ; *SARS-CoV-2/immunology/isolation & purification ; },
abstract = {UNLABELLED: The COVID-19 pandemic has caused an unprecedented public health, social, and economic crisis. Improving understanding on available tests for detecting COVID-19 is critical for effective management of the pandemic. We proposed that a multidisciplinary expert panel can establish recommendations on ideal use of diagnostic tools, with a focus on RT-PCR and serological high-affinity antibodies (both IgM and IgG) tests for the Latin America region.

STUDY DESIGN: A collaborative multidisciplinary panel of 5 recognized experts in Latin America (an infectious disease specialist, three pathologists, and an immunologist) was convened and supported by Roche Diagnostics to develop standard guidelines and an evidence-based document of best practices on the use of diagnostic tools for COVID-19.

RESULTS: The authors reached consensus on the applicability of diagnostic tools to provide testing algorithms for the use of RT-PCR and serological high-affinity antibodies (both IgM and IgG) tests in three settings: 1) For asymptomatic subjects exposed to a SARS-CoV-2 infected person; 2) For epidemiological purposes and; 3) For symptomatic subjects.

CONCLUSION: The serological high-affinity SARS-CoV-2 antibodies (both IgM and IgG) tests play a key role in COVID-19 diagnosis. These tests can be applied for suspected false-negative RT-PCR results and for individual determination of response. The use of these tests can also contribute greatly to public health strategies, such as population screening and supporting vaccination planning. Serological status for high-affinity antibodies (both IgM and IgG) should be performed ideally 21 days after potential infectious contact, given that the majority of exposed individuals will have seroconverted.},
}

Algorithms
Antibodies, Viral/*blood
COVID-19/*diagnosis
COVID-19 Testing/*methods
Consensus
Humans
Reverse Transcriptase Polymerase Chain Reaction/*methods
*SARS-CoV-2/immunology/isolation & purification

@article {pmid33213540,
year = {2021},
author = {Khan, S and Tsang, KK and Mertz, D and Dolovich, M and Tunks, M and Demers, C and Hassall, K and Maharaj, N and Margallo, K and Cividino, M and Chagla, Z and Duong, M},
title = {A regional Canadian expert consensus on recommendations for restoring exercise and pulmonary function testing in low and moderate-to-high community prevalence coronavirus disease 2019 (COVID-19) settings.},
journal = {Infection control and hospital epidemiology},
volume = {42},
number = {12},
pages = {1535-1537},
pmid = {33213540},
issn = {1559-6834},
mesh = {*COVID-19 ; Canada/epidemiology ; Consensus ; Humans ; Prevalence ; SARS-CoV-2 ; },
}

*COVID-19
Canada/epidemiology
Consensus
Humans
Prevalence
SARS-CoV-2

@article {pmid33187758,
year = {2021},
author = {Luo, Y and Yuan, J and Liu, M and Fang, N and Bai, J and Fei, X and Deng, Y and Yu, T and Mao, J and Zhu, H and Li, C and Peng, Q and Zhang, M and Zeng, S and Xu, G and Niu, C and Dong, T and He, W and Tang, J},
title = {Chinese Expert Consensus on Protection for Ultrasound Healthcare Workers against COVID-19.},
journal = {Ultrasound in medicine & biology},
volume = {47},
number = {2},
pages = {222-229},
pmid = {33187758},
issn = {1879-291X},
mesh = {COVID-19/*prevention & control ; China ; Consensus ; Disinfection ; *Health Personnel ; Humans ; Infectious Disease Transmission, Patient-to-Professional/*prevention & control ; Occupational Exposure/prevention & control ; Personal Protective Equipment ; Quarantine ; Triage ; Ultrasonography/*methods ; },
abstract = {Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a worldwide pandemic and poses a serious public health risk. It has been proven that lung ultrasound can be extremely valuable in the diagnosis and treatment of the disease, which could also minimize the number of exposed healthcare workers and equipment. Because healthcare workers in ultrasound departments are in close contact with patients who might be infected or virus carriers, it is extremely important that they be provided sufficient protection. Extremely aggressive protection should be avoided because it might lead to a lack of protection equipment for the hospital. Guidance on proper protection management should be provided in detail, for example, how to choose personal protective equipment, how to disinfect the environment. To address these problems, on behalf of the Chinese Ultrasound Doctors Association, Chinese PLA Professional Committee of Ultrasound in Medicine, Beijing Institute of Ultrasound in Medicine and Chinese Research Hospital Association Ultrasound Professional Committee, the authors have summarized the recommendations for effective protection according to existing hygienic standards, their experience and available literature. After the recommendations were completed, two online conferences were held on January 31, 2020 and February 7, 2020, at which the recommendations were discussed in detail. A modified version of the work was circulated and finally approved by all authors, and is the present Chinese Expert Consensus on Protection for Ultrasound Healthcare Workers against COVID-19.},
}

COVID-19/*prevention & control
China
Consensus
Disinfection
*Health Personnel
Humans
Infectious Disease Transmission, Patient-to-Professional/*prevention & control
Occupational Exposure/prevention & control
Personal Protective Equipment
Quarantine
Triage
Ultrasonography/*methods

@article {pmid33185026,
year = {2021},
author = {Tandogdu, Z and Collins, J and Shaw, G and Rohn, J and Koves, B and Sachdeva, A and Ghazi, A and Haese, A and Mottrie, A and Kumar, A and Sivaraman, A and Tewari, A and Challacombe, B and Rocco, B and Giedelman, C and Wagner, C and Rogers, CG and Murphy, DG and Pushkar, D and Ogaya-Pinies, G and Porter, J and Seetharam, KR and Graefen, M and Orvieto, MA and Moschovas, MC and Schatloff, O and Wiklund, P and Coelho, R and Valero, R and de Reijke, TM and Ahlering, T and Rogers, T and van der Poel, HG and Patel, V and Artibani, W and Wagenlehner, F and Maes, K and Rha, KH and Nathan, S and Bjerklund Johansen, TE and Hawkey, P and Kelly, J},
title = {Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement.},
journal = {BJU international},
volume = {127},
number = {6},
pages = {729-741},
doi = {10.1111/bju.15299},
pmid = {33185026},
issn = {1464-410X},
mesh = {COVID-19/*epidemiology ; *Critical Pathways ; Delphi Technique ; Health Care Rationing ; Humans ; Infection Control ; Male ; *Pandemics ; *Prostatectomy ; Prostatic Neoplasms/*surgery ; SARS-CoV-2 ; Time-to-Treatment ; },
abstract = {OBJECTIVE: Coronavirus disease-19 (COVID-19) pandemic caused delays in definitive treatment of patients with prostate cancer. Beyond the immediate delay a backlog for future patients is expected. The objective of this work is to develop guidance on criteria for prioritisation of surgery and reconfiguring management pathways for patients with non-metastatic prostate cancer who opt for surgical treatment. A second aim was to identify the infection prevention and control (IPC) measures to achieve a low likelihood of coronavirus disease 2019 (COVID-19) hazard if radical prostatectomy (RP) was to be carried out during the outbreak and whilst the disease is endemic.

METHODS: We conducted an accelerated consensus process and systematic review of the evidence on COVID-19 and reviewed international guidance on prostate cancer. These were presented to an international prostate cancer expert panel (n = 34) through an online meeting. The consensus process underwent three rounds of survey in total. Additions to the second- and third-round surveys were formulated based on the answers and comments from the previous rounds. The Consensus opinion was defined as ≥80% agreement and this was used to reconfigure the prostate cancer pathways.

RESULTS: Evidence on the delayed management of patients with prostate cancer is scarce. There was 100% agreement that prostate cancer pathways should be reconfigured and measures developed to prevent nosocomial COVID-19 for patients treated surgically. Consensus was reached on prioritisation criteria of patients for surgery and management pathways for those who have delayed treatment. IPC measures to achieve a low likelihood of nosocomial COVID-19 were coined as 'COVID-19 cold' sites.

CONCLUSION: Reconfiguring management pathways for patients with prostate cancer is recommended if significant delay (>3-6 months) in surgical management is unavoidable. The mapped pathways provide guidance for such patients. The IPC processes proposed provide a framework for providing RP within an environment with low COVID-19 risk during the outbreak or when the disease remains endemic. The broader concepts could be adapted to other indications beyond prostate cancer surgery.},
}

COVID-19/*epidemiology
*Critical Pathways
Delphi Technique
Health Care Rationing
Humans
Infection Control
Male
*Pandemics
*Prostatectomy
Prostatic Neoplasms/*surgery
SARS-CoV-2
Time-to-Treatment

@article {pmid33179744,
year = {2021},
author = {Baldassarre, LA and Yang, EH and Cheng, RK and DeCara, JM and Dent, S and Liu, JE and Rudski, LG and Strom, JB and Thavendiranathan, P and Barac, A and Zaha, VG and Bucciarelli-Ducci, C and Ellahham, S and Deswal, A and Lenneman, C and Villarraga, HR and Blaes, AH and Ismail-Khan, R and Ky, B and Leja, MJ and Scherrer-Crosbie, M},
title = {Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils.},
journal = {Journal of the National Cancer Institute},
volume = {113},
number = {5},
pages = {513-522},
pmid = {33179744},
issn = {1460-2105},
support = {K23 HL144907/HL/NHLBI NIH HHS/United States ; R01 HL130539/HL/NHLBI NIH HHS/United States ; UL1 TR001863/TR/NCATS NIH HHS/United States ; },
mesh = {COVID-19/*complications/transmission/virology ; Cardiotoxicity/diagnosis/*therapy/virology ; Cardiovascular Diseases/diagnosis/*therapy/virology ; Diagnostic Imaging/*methods ; Expert Testimony ; Humans ; Neoplasms/diagnosis/*therapy/virology ; SARS-CoV-2/*isolation & purification ; },
abstract = {In response to the coronavirus disease 2019 (COVID-19) pandemic, the Cardio-Oncology and Imaging Councils of the American College of Cardiology offers recommendations to clinicians regarding the cardiovascular care of cardio-oncology patients in this expert consensus statement. Cardio-oncology patients-individuals with an active or prior cancer history and with or at risk of cardiovascular disease-are a rapidly growing population who are at increased risk of infection, and experiencing severe and/or lethal complications by COVID-19. Recommendations for optimizing screening and monitoring visits to detect cardiac dysfunction are discussed. In addition, judicious use of multimodality imaging and biomarkers are proposed to identify myocardial, valvular, vascular, and pericardial involvement in cancer patients. The difficulties of diagnosing the etiology of cardiovascular complications in patients with cancer and COVID-19 are outlined, along with weighing the advantages against risks of exposure, with the modification of existing cardiovascular treatments and cardiotoxicity surveillance in patients with cancer during the COVID-19 pandemic.},
}

COVID-19/*complications/transmission/virology
Cardiotoxicity/diagnosis/*therapy/virology
Cardiovascular Diseases/diagnosis/*therapy/virology
Diagnostic Imaging/*methods
Expert Testimony
Humans
Neoplasms/diagnosis/*therapy/virology
SARS-CoV-2/*isolation & purification

@article {pmid33178656,
year = {2020},
author = {Bhaskar, S and Bradley, S and Chattu, VK and Adisesh, A and Nurtazina, A and Kyrykbayeva, S and Sakhamuri, S and Yaya, S and Sunil, T and Thomas, P and Mucci, V and Moguilner, S and Israel-Korn, S and Alacapa, J and Mishra, A and Pandya, S and Schroeder, S and Atreja, A and Banach, M and Ray, D},
title = {Telemedicine Across the Globe-Position Paper From the COVID-19 Pandemic Health System Resilience PROGRAM (REPROGRAM) International Consortium (Part 1).},
journal = {Frontiers in public health},
volume = {8},
number = {},
pages = {556720},
pmid = {33178656},
issn = {2296-2565},
mesh = {*COVID-19 ; Humans ; Pandemics/prevention & control ; Public Health ; SARS-CoV-2 ; *Telemedicine ; },
abstract = {Coronavirus disease 2019 (COVID-19) has accelerated the adoption of telemedicine globally. The current consortium critically examines the telemedicine frameworks, identifies gaps in its implementation and investigates the changes in telemedicine framework/s during COVID-19 across the globe. Streamlining of global public health preparedness framework that is interoperable and allow for collaboration and sharing of resources, in which telemedicine is an integral part of the public health response during outbreaks such as COVID-19, should be pursued. With adequate reinforcement, telemedicine has the potential to act as the "safety-net" of our public health response to an outbreak. Our focus on telemedicine must shift to the developing and under-developing nations, which carry a disproportionate burden of vulnerable communities who are at risk due to COVID-19.},
}

*COVID-19
Humans
Pandemics/prevention & control
Public Health
SARS-CoV-2
*Telemedicine

@article {pmid33166525,
year = {2021},
author = {Freeman-Sanderson, A and Ward, EC and Miles, A and de Pedro Netto, I and Duncan, S and Inamoto, Y and McRae, J and Pillay, N and Skoretz, SA and Walshe, M and Brodsky, MB and , },
title = {A Consensus Statement for the Management and Rehabilitation of Communication and Swallowing Function in the ICU: A Global Response to COVID-19.},
journal = {Archives of physical medicine and rehabilitation},
volume = {102},
number = {5},
pages = {835-842},
pmid = {33166525},
issn = {1532-821X},
mesh = {COVID-19/complications/*rehabilitation ; Communication Disorders/etiology/*rehabilitation ; Consensus ; Critical Care/*standards ; Deglutition Disorders/etiology/*rehabilitation ; Delphi Technique ; Humans ; Intensive Care Units/standards ; Physical Therapy Modalities/*standards ; Respiration, Artificial/adverse effects ; SARS-CoV-2 ; Speech Therapy/methods/*standards ; Speech-Language Pathology/standards ; },
abstract = {OBJECTIVE: To identify core practices for workforce management of communication and swallowing functions in coronavirus disease 2019 (COVID-19) positive patients within the intensive care unit (ICU).

DESIGN: A modified Delphi methodology was used, with 3 electronic voting rounds. AGREE II and an adapted COVID-19 survey framework from physiotherapy were used to develop survey statements. Sixty-six statements pertaining to workforce planning and management of communication and swallowing function in the ICU were included.

SETTING: Electronic modified Delphi process.

PARTICIPANTS: Speech-language pathologists (SLPs) (N=35) from 6 continents representing 12 countries.

INTERVENTIONS: Not applicable.

MAIN OUTCOME MEASURES: The main outcome was consensus agreement, defined a priori as ≥70% of participants with a mean Likert score ≥7.0 (11-point scale: 0=strongly disagree, 10=strongly agree). Prioritization rank order of statements in a fourth round was also conducted.

RESULTS: SLPs with a median of 15 years of ICU experience, working primarily in clinical (54%), academic (29%), or managerial positions (17%), completed all voting rounds. After the third round, 64 statements (97%) met criteria. Rank ordering identified issues of high importance.

CONCLUSIONS: A set of global consensus statements to facilitate planning and delivery of rehabilitative care for patients admitted to the ICU during the COVID-19 pandemic were agreed by an international expert SLP group. Statements focused on considerations for workforce preparation, resourcing and training, and the management of communication and swallowing functions. These statements support and provide direction for all members of the rehabilitation team to use for patients admitted to the ICU during a global pandemic.},
}

COVID-19/complications/*rehabilitation
Communication Disorders/etiology/*rehabilitation
Consensus
Critical Care/*standards
Deglutition Disorders/etiology/*rehabilitation
Delphi Technique
Humans
Intensive Care Units/standards
Physical Therapy Modalities/*standards
Respiration, Artificial/adverse effects
SARS-CoV-2
Speech Therapy/methods/*standards
Speech-Language Pathology/standards

@article {pmid33146360,
year = {2020},
author = {Chagas, AL and Fonseca, LGD and Coelho, FF and Saud, LRDC and Abdala, E and Andraus, W and Fiore, L and Moreira, AM and Menezes, MR and Carnevale, FC and Tani, CM and Alencar, RSSM and D'Albuquerque, LAC and Herman, P and Carrilho, FJ},
title = {Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement.},
journal = {Clinics (Sao Paulo, Brazil)},
volume = {75},
number = {},
pages = {e2192},
pmid = {33146360},
issn = {1980-5322},
mesh = {Betacoronavirus ; Brazil/epidemiology ; COVID-19 ; *Carcinoma, Hepatocellular/epidemiology/therapy ; Consensus ; *Coronavirus Infections ; Humans ; *Liver Neoplasms/epidemiology/therapy ; *Pandemics ; *Pneumonia, Viral ; SARS-CoV-2 ; },
abstract = {More than 18 million people in 188 countries have been diagnosed as having coronavirus disease (COVID-19), and COVID-19 has been responsible for more than 600,000 deaths worldwide. Brazil is now the second most affected country globally. Faced with this scenario, various public health measures and changes in the daily routines of hospitals were implemented to stop the pandemic. Patients with hepatocellular carcinoma (HCC) are at an increased risk for severe COVID-19 as they present with two major diseases: cancer and concomitant chronic liver disease. The COVID-19 pandemic can significantly impact the management of HCC patients from diagnosis to treatment strategies. These patients need special attention and assistance at this time, especially since treatment for tumors cannot be delayed in most cases. The aim of this guideline was to standardize the management of HCC patients during the COVID-19 pandemic. This document was developed, on the basis of the best evidence available, by a multidisciplinary team from Instituto do Câncer do Estado de São Paulo (ICESP), and Instituto Central of the Hospital das Clínicas da Universidade de São Paulo (HC-FMUSP), which are members of the São Paulo Clínicas Liver Cancer Group.},
}

Betacoronavirus
Brazil/epidemiology
COVID-19
*Carcinoma, Hepatocellular/epidemiology/therapy
Consensus
*Coronavirus Infections
Humans
*Liver Neoplasms/epidemiology/therapy
*Pandemics
*Pneumonia, Viral
SARS-CoV-2

@article {pmid33132066,
year = {2021},
author = {García-Salido, A and Antón, J and Martínez-Pajares, JD and Giralt Garcia, G and Gómez Cortés, B and Tagarro, A and , and , and Belda Hofheinz, S and Calvo Penadés, I and de Carlos Vicente, JC and Grasa Lozano, CD and Hernández Bou, S and Pino Ramírez, RM and Núñez Cuadros, E and Pérez-Lescure Picarzo, J and Saavedra Lozano, J and Salas-Mera, D and Villalobos Pinto, E},
title = {[Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS)].},
journal = {Anales de pediatria},
volume = {94},
number = {2},
pages = {116.e1-116.e11},
pmid = {33132066},
issn = {2341-2879},
mesh = {Algorithms ; COVID-19/*diagnosis/*therapy/complications ; Child ; Humans ; Systemic Inflammatory Response Syndrome/*diagnosis/*therapy ; },
abstract = {A new paediatric multisystem inflammatory syndrome, linked to SARS-CoV-2, has been described. The clinical picture is variable and is associated with an active or recent infection due to SARS-CoV-2. A review of the existing literature by a multidisciplinary group of paediatric specialists is presented in this document. Later, they make recommendations on the stabilisation, diagnosis, and treatment of this syndrome.},
}

Algorithms
COVID-19/*diagnosis/*therapy/complications
Child
Humans
Systemic Inflammatory Response Syndrome/*diagnosis/*therapy

@article {pmid33123943,
year = {2021},
author = {Defrancesco, M and Bancher, C and Dal-Bianco, P and Hinterhuber, H and Schmidt, R and Struhal, W and Ransmayr, G and Stögmann, E and Marksteiner, J},
title = {[Position paper of the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft, ÖAG) : Effects of the COVID-19 pandemic in Austria on people with dementia and their care environment-problem areas, recommendations, and strategies].},
journal = {Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater},
volume = {35},
number = {1},
pages = {35-47},
pmid = {33123943},
issn = {2194-1327},
mesh = {Aged ; Aged, 80 and over ; *Alzheimer Disease/therapy ; Austria ; *COVID-19/epidemiology ; Communicable Disease Control ; *Dementia/therapy ; Humans ; *Pandemics ; Practice Guidelines as Topic ; SARS-CoV-2 ; },
abstract = {Older adults are particularly affected by the current COVID-19 (SARS-CoV-2) pandemic. The risk of dying from COVID-19 increases with age and is often associated with pre-existing health conditions. Globally, more than 50 million-in Austria currently approximately 140,000 people-suffer from dementia. The co-occurrence of dementia as a "pandemic of old age" together with the COVID-19 pandemic has a double impact on persons living with dementia and their caregivers. The COVID-19 pandemic poses major challenges for individuals with dementia and their caregivers: (1) People with dementia have limited access to information on COVID-19, may have difficulties with protective measures such as wearing masks and in remembering safety regulations. (2) People with dementia live alone or with their family, or are institutionalized. To reduce the chance of infection among older people in nursing homes, Austrian local authorities have banned visitors to nursing homes and long-term care facilities and implemented strict social-distancing measures. As a result, older people lost face-to-face contact with their family members, became isolated and social activities stopped. Consequently, anxiety, stress and serious concerns about infections among staff in nursing homes increased and they developed signs of exhaustion and burnout during the full lockdown of the facilities. Thus, due to the emerging COVID-19 crisis, the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft, ÖAG) and international societies developed recommendations to support people living with dementia and their caregivers on various issues of physical and mental health.},
}

Aged
Aged, 80 and over
*Alzheimer Disease/therapy
Austria
*COVID-19/epidemiology
Communicable Disease Control
*Dementia/therapy
Humans
*Pandemics
Practice Guidelines as Topic
SARS-CoV-2

@article {pmid33089297,
year = {2020},
author = {Zhu, L and Wang, JB and Yu, Q and Huang, ZW and Han, FK and Li, SJ and Sha, Y and Shi, HM and Tao, XF},
title = {[Shanghai municipal expert consensus on standardized prevention and control of COVID-19 during procedures of oral radiology].},
journal = {Shanghai kou qiang yi xue = Shanghai journal of stomatology},
volume = {29},
number = {4},
pages = {431-434},
pmid = {33089297},
issn = {1006-7248},
mesh = {Betacoronavirus ; COVID-19 ; China ; Consensus ; *Coronavirus Infections ; Humans ; *Pandemics ; *Pneumonia, Viral ; *Radiography, Dental ; SARS-CoV-2 ; },
abstract = {The announcement of National Health Commission on January 20, 2020 (No.1 of 2020) has included novel coronavirus pneumonia into the B class infectious diseases according to the law of the People's Republic of China on the prevention and control of infectious diseases, and has been managed as A class infectious diseases. People's governments at all levels and health administration departments have been paying high attention to it. With the alleviation of COVID-19 nationwide, dental clinics gradually resume to work. The main transmission routes of COVID-19 are respiratory droplets and contact transmission, hence oral radiological examination is kind of a high-risk operation. Standardized radiologic process is of great significance to reduce the risk of COVID-19 transmission. In accordance with the national and Shanghai epidemic prevention requirements, and in combination with the actual situation of various medical institutions, Oral and Maxillofacial Radiology Committee of Shanghai Stomatological Association formulated the expert consensus on standardized prevention and control of COVID-19 for clinical reference. This recommendation will be updated according to the situation of epidemic prevention and control in China and the new relevant diagnosis and treatment plans.},
}

Betacoronavirus
COVID-19
China
Consensus
*Coronavirus Infections
Humans
*Pandemics
*Pneumonia, Viral
*Radiography, Dental
SARS-CoV-2

@article {pmid33075144,
year = {2021},
author = {Klimek, L and Jutel, M and Bousquet, J and Agache, I and Akdis, CA and Hox, V and Gevaert, P and Tomazic, PV and Rondon, C and Cingi, C and Toppila-Salmi, S and Karavelia, A and Bozkurt, B and Förster-Ruhrmann, U and Becker, S and Chaker, AM and Wollenberg, B and Mösges, R and Huppertz, T and Hagemann, J and Bachert, C and Fokkens, W},
title = {Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper.},
journal = {Allergy},
volume = {76},
number = {3},
pages = {677-688},
doi = {10.1111/all.14629},
pmid = {33075144},
issn = {1398-9995},
mesh = {Adrenal Cortex Hormones/administration & dosage ; Asthma/drug therapy ; Biological Products/therapeutic use ; COVID-19/*epidemiology ; Chronic Disease ; Humans ; Nasal Polyps/drug therapy ; Rhinitis/*drug therapy ; *SARS-CoV-2 ; Sinusitis/*drug therapy ; },
abstract = {BACKGROUND: Chronic rhinosinusitis is regarded as a chronic airway disease. According to WHO recommendations, it may be a risk factor for COVID-19 patients. In most CRSwNP cases, the inflammatory changes affecting the nasal and paranasal mucous membranes are type-2 (T2) inflammation endotypes.

METHODS: The current knowledge on COVID-19 and on treatment options for CRS was analyzed by a literature search in Medline, Pubmed, international guidelines, the Cochrane Library and the Internet.

RESULTS: Based on international literature, on current recommendations by WHO and other international organizations as well as on previous experience, a panel of experts from EAACI and ARIA provided recommendations for the treatment of CRS during the COVID-19 pandemic.

CONCLUSION: Intranasal corticosteroids remain the standard treatment for CRS in patients with SARS-CoV-2 infection. Surgical treatments should be reduced to a minimum and surgery preserved for patients with local complications and for those with no other treatment options. Systemic corticosteroids should be avoided. Treatment with biologics can be continued with careful monitoring in noninfected patients and should be temporarily interrupted during the course of the COVID-19 infection.},
}

Adrenal Cortex Hormones/administration & dosage
Asthma/drug therapy
Biological Products/therapeutic use
COVID-19/*epidemiology
Chronic Disease
Humans
Nasal Polyps/drug therapy
Rhinitis/*drug therapy
*SARS-CoV-2
Sinusitis/*drug therapy

@article {pmid33040381,
year = {2021},
author = {Irons, JF and Pavey, W and Bennetts, JS and Granger, E and Tutungi, E and Almeida, A},
title = {COVID-19 safety: aerosol-generating procedures and cardiothoracic surgery and anaesthesia - Australian and New Zealand consensus statement.},
journal = {The Medical journal of Australia},
volume = {214},
number = {1},
pages = {40-44},
pmid = {33040381},
issn = {1326-5377},
mesh = {*Aerosols ; Anesthesia ; Australia ; COVID-19/epidemiology/*prevention & control/transmission ; Cardiac Surgical Procedures ; Consensus ; Health Personnel/education ; Humans ; Infection Control/*methods ; Infectious Disease Transmission, Patient-to-Professional/*prevention & control ; New Zealand ; *SARS-CoV-2 ; Societies, Medical ; Thoracic Surgical Procedures ; },
abstract = {INTRODUCTION: Coronavirus disease 2019 (COVID-19) is a contagious disease that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Health care workers are at risk of infection from aerosolisation of respiratory secretions, droplet and contact spread. There are a number of procedures that represent a high risk of aerosol generation during cardiothoracic surgery. It is important that adequate training, equipment and procedures are in place to reduce that risk.

RECOMMENDATIONS: We provide a number of key recommendations, which reduce the risk of aerosol generation during cardiothoracic surgery and help protect patients and staff. These include general measures such as patient risk stratification, appropriate use of personal protective equipment, consideration to delay surgery in positive patients, and careful attention to theatre planning and preparation. There are also recommended procedural interventions during airway management, transoesophageal echocardiography, cardiopulmonary bypass, chest drain management and specific cardiothoracic surgical procedures. Controversies exist regarding the management of low risk patients undergoing procedures at high risk of aerosol generation, and recommendations for these patients will change depending on the regional prevalence, risk of community transmission and the potential for asymptomatic patients attending for these procedures.

This statement reflects changes in management based on expert opinion, national guidelines and available evidence. Our knowledge with regard to COVID-19 continues to evolve and with this, guidance may change and develop. Our colleagues are urged to follow national guidelines and institutional recommendations regarding best practices to protect their patients and themselves.

ENDORSED BY: Australian and New Zealand Society of Cardiac and Thoracic Surgeons and the Anaesthetic Continuing Education Cardiac Thoracic Vascular and Perfusion Special Interest Group.},
}

*Aerosols
Anesthesia
Australia
COVID-19/epidemiology/*prevention & control/transmission
Cardiac Surgical Procedures
Consensus
Health Personnel/education
Humans
Infection Control/*methods
Infectious Disease Transmission, Patient-to-Professional/*prevention & control
New Zealand
*SARS-CoV-2
Societies, Medical
Thoracic Surgical Procedures

@article {pmid33034302,
year = {2020},
author = {Banothu, KK and Bhat, JI and Das, RR and Dhochak, N and Ghimire, JJ and Goyal, JP and Gulla, KM and Gupta, S and Jat, KR and Kabra, SK and Kalyan, P and Kumar, A and Kumar, P and Kumar, V and Lodha, R and Mathew, JL and Pathania, A and Ratageri, VH and Singh, V and Warankar, S},
title = {Expert Opinion on Restoration of Pediatric Pulmonology Services During the SARS-CoV-2 Pandemic.},
journal = {Indian pediatrics},
volume = {57},
number = {11},
pages = {1055-1059},
pmid = {33034302},
issn = {0974-7559},
mesh = {Airway Management ; COVID-19/*epidemiology/prevention & control/transmission ; COVID-19 Testing ; Chronic Disease/therapy ; Cross Infection/prevention & control ; Diagnostic Techniques, Respiratory System ; Emergency Service, Hospital/organization & administration ; Humans ; India/epidemiology ; Infection Control ; Nebulizers and Vaporizers ; Noninvasive Ventilation ; *Pandemics ; Patient Admission ; *Pediatrics ; Personal Protective Equipment ; Pulmonary Medicine/*organization & administration ; Respiratory Tract Diseases/therapy ; SARS-CoV-2 ; Telemedicine ; Triage ; },
}

Airway Management
COVID-19/*epidemiology/prevention & control/transmission
COVID-19 Testing
Chronic Disease/therapy
Cross Infection/prevention & control
Diagnostic Techniques, Respiratory System
Emergency Service, Hospital/organization & administration
Humans
India/epidemiology
Infection Control
Nebulizers and Vaporizers
Noninvasive Ventilation
*Pandemics
Patient Admission
*Pediatrics
Personal Protective Equipment
Pulmonary Medicine/*organization & administration
Respiratory Tract Diseases/therapy
SARS-CoV-2
Telemedicine
Triage

@article {pmid33034142,
year = {2020},
author = {Haines, J and Esposito, K and Slinger, C and Pargeter, N and Murphy, J and Selby, J and Prior, K and Mansur, A and Vyas, A and Stanton, AE and Sabroe, I and Hull, JH and Fowler, SJ},
title = {UK consensus statement on the diagnosis of inducible laryngeal obstruction in light of the COVID-19 pandemic.},
journal = {Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology},
volume = {50},
number = {12},
pages = {1287-1293},
pmid = {33034142},
issn = {1365-2222},
mesh = {Airway Obstruction/*diagnosis ; *COVID-19 ; Consensus ; *Critical Pathways ; Humans ; Laryngeal Diseases/*diagnosis ; SARS-CoV-2 ; United Kingdom ; },
abstract = {Prior to the COVID-19 pandemic, laryngoscopy was the mandatory gold standard for the accurate assessment and diagnosis of inducible laryngeal obstruction. However, upper airway endoscopy is considered an aerosol-generating procedure in professional guidelines, meaning routine procedures are highly challenging and the availability of laryngoscopy is reduced. In response, we have convened a multidisciplinary panel with broad experience in managing this disease and agreed a recommended strategy for presumptive diagnosis in patients who cannot have laryngoscopy performed due to pandemic restrictions. To maintain clinical standards whilst ensuring patient safety, we discuss the importance of triage, information gathering, symptom assessment and early review of response to treatment. The consensus recommendations will also be potentially relevant to other future situations where access to laryngoscopy is restricted, although we emphasize that this investigation remains the gold standard.},
}

Airway Obstruction/*diagnosis
*COVID-19
Consensus
*Critical Pathways
Humans
Laryngeal Diseases/*diagnosis
SARS-CoV-2
United Kingdom

@article {pmid33027040,
year = {2020},
author = {Bossuyt, X and Damoiseaux, J and Rasmussen, N and van Paassen, P and Hellmich, B and Baslund, B and Blockmans, D and Vermeersch, P and Lopez-Hoyos, M and Vercammen, M and Barret, E and Hammar, F and Leinfelder, U and Mahler, M and Olschowka, N and Roggenbuck, D and Schlumberger, W and Walker, R and Rönnelid, J and Cohen Tervaert, JW and Csernok, E and Fierz, W and , },
title = {Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper.},
journal = {Clinical chemistry and laboratory medicine},
volume = {59},
number = {2},
pages = {e35-e39},
doi = {10.1515/cclm-2020-1178},
pmid = {33027040},
issn = {1437-4331},
mesh = {Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/blood/*diagnosis/immunology ; Antibodies, Antineutrophil Cytoplasmic/*blood ; Calibration ; Data Interpretation, Statistical ; Diagnosis, Differential ; Humans ; Immunoassay/methods/*standards ; Likelihood Functions ; Myeloblastin/immunology ; Peroxidase/immunology ; Reference Standards ; Sensitivity and Specificity ; },
}

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/blood/*diagnosis/immunology
Antibodies, Antineutrophil Cytoplasmic/*blood
Calibration
Data Interpretation, Statistical
Diagnosis, Differential
Humans
Immunoassay/methods/*standards
Likelihood Functions
Myeloblastin/immunology
Peroxidase/immunology
Reference Standards
Sensitivity and Specificity

@article {pmid33014958,
year = {2020},
author = {Bhaskar, S and Bradley, S and Chattu, VK and Adisesh, A and Nurtazina, A and Kyrykbayeva, S and Sakhamuri, S and Moguilner, S and Pandya, S and Schroeder, S and Banach, M and Ray, D},
title = {Telemedicine as the New Outpatient Clinic Gone Digital: Position Paper From the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (Part 2).},
journal = {Frontiers in public health},
volume = {8},
number = {},
pages = {410},
pmid = {33014958},
issn = {2296-2565},
mesh = {*Ambulatory Care Facilities ; COVID-19/*prevention & control ; Health Personnel ; Humans ; Pandemics ; Physical Distancing ; Telemedicine/*trends ; Videoconferencing ; },
abstract = {Technology has acted as a great enabler of patient continuity through remote consultation, ongoing monitoring, and patient education using telephone and videoconferencing in the coronavirus disease 2019 (COVID-19) era. The devastating impact of COVID-19 is bound to prevail beyond its current reign. The vulnerable sections of our community, including the elderly, those from lower socioeconomic backgrounds, those with multiple comorbidities, and immunocompromised patients, endure a relatively higher burden of a pandemic such as COVID-19. The rapid adoption of different technologies across countries, driven by the need to provide continued medical care in the era of social distancing, has catalyzed the penetration of telemedicine. Limiting the exposure of patients, healthcare workers, and systems is critical in controlling the viral spread. Telemedicine offers an opportunity to improve health systems delivery, access, and efficiency. This article critically examines the current telemedicine landscape and challenges in its adoption, toward remote/tele-delivery of care, across various medical specialties. The current consortium provides a roadmap and/or framework, along with recommendations, for telemedicine uptake and implementation in clinical practice during and beyond COVID-19.},
}

*Ambulatory Care Facilities
COVID-19/*prevention & control
Health Personnel
Humans
Pandemics
Physical Distancing
Telemedicine/*trends
Videoconferencing

@article {pmid32969160,
year = {2020},
author = {Verbruggen, LC and Wang, Y and Armenian, SH and Ehrhardt, MJ and van der Pal, HJH and van Dalen, EC and van As, JW and Bardi, E and Baust, K and Berger, C and Castagnola, E and Devine, KA and Gebauer, J and Marchak, JG and Glaser, AW and Groll, AH and Haeusler, GM and den Hartogh, J and Haupt, R and Hjorth, L and Kato, M and Kepák, T and Koopman, MMWR and Langer, T and Maeda, M and Michel, G and Muraca, M and Nathan, PC and van den Oever, SR and Pavasovic, V and Sato, S and Schulte, F and Sung, L and Tissing, W and Uyttebroeck, A and Mulder, RL and Kuehni, C and Skinner, R and Hudson, MM and Kremer, LCM},
title = {Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group.},
journal = {Pediatric blood & cancer},
volume = {67},
number = {12},
pages = {e28702},
pmid = {32969160},
issn = {1545-5017},
mesh = {Adolescent ; Adult ; *Betacoronavirus ; COVID-19 ; *Cancer Survivors ; Child ; Child, Preschool ; Coronavirus Infections/epidemiology/*prevention & control/*therapy/transmission ; Female ; Humans ; Male ; Neoplasms/epidemiology/*therapy ; Pandemics/*prevention & control ; Pneumonia, Viral/epidemiology/*prevention & control/*therapy/transmission ; Practice Guidelines as Topic ; SARS-CoV-2 ; Young Adult ; },
abstract = {Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.},
}

Adolescent
Adult
*Betacoronavirus
COVID-19
*Cancer Survivors
Child
Child, Preschool
Coronavirus Infections/epidemiology/*prevention & control/*therapy/transmission
Female
Humans
Male
Neoplasms/epidemiology/*therapy
Pandemics/*prevention & control
Pneumonia, Viral/epidemiology/*prevention & control/*therapy/transmission
Practice Guidelines as Topic
SARS-CoV-2
Young Adult

@article {pmid32945570,
year = {2020},
author = {Bryant, PA and Rogers, BA and Cowan, R and Bowen, AC and Pollard, J and , },
title = {Planning and clinical role of acute medical home care services for COVID-19: consensus position statement by the Hospital-in-the-Home Society Australasia.},
journal = {Internal medicine journal},
volume = {50},
number = {10},
pages = {1267-1271},
pmid = {32945570},
issn = {1445-5994},
mesh = {Australasia/epidemiology ; Betacoronavirus ; COVID-19 ; Communication ; Coronavirus Infections/*epidemiology/*therapy ; Equipment and Supplies, Hospital/supply & distribution ; Health Workforce/organization & administration ; Home Care Services/*organization & administration ; Humans ; Infection Control/organization & administration ; Occupational Exposure/prevention & control ; Pandemics ; Patient-Centered Care/organization & administration ; Pneumonia, Viral/*epidemiology/*therapy ; SARS-CoV-2 ; Workload ; },
abstract = {During a pandemic when hospitals are stretched and patients need isolation, the role of hospital-in-the-home (HITH) providing acute medical care at home has never been more relevant. We aimed to define and address the challenges to acute home care services posed by the COVID-19 pandemic. Planning for service operation involves staffing, equipment availability and cleaning, upskilling in telehealth and communication. Planning for clinical care involves maximising cohorts of patients without COVID-19 and new clinical pathways for patients with COVID-19. The risk of SARS-CoV-2 transmission, specific COVID-19 clinical pathways and the well-being of patients and staff should be addressed in advance.},
}

Australasia/epidemiology
Betacoronavirus
COVID-19
Communication
Coronavirus Infections/*epidemiology/*therapy
Equipment and Supplies, Hospital/supply & distribution
Health Workforce/organization & administration
Home Care Services/*organization & administration
Humans
Infection Control/organization & administration
Occupational Exposure/prevention & control
Pandemics
Patient-Centered Care/organization & administration
Pneumonia, Viral/*epidemiology/*therapy
SARS-CoV-2
Workload

@article {pmid32941344,
year = {2020},
author = {Oliva, A and Caputo, M and Grassi, S and Vetrugno, G and Marazza, M and Ponzanelli, G and Cauda, R and Scambia, G and Forti, G and Bellantone, R and Pascali, VL},
title = {Liability of Health Care Professionals and Institutions During COVID-19 Pandemic in Italy: Symposium Proceedings and Position Statement.},
journal = {Journal of patient safety},
volume = {16},
number = {4},
pages = {e299-e302},
pmid = {32941344},
issn = {1549-8425},
mesh = {Betacoronavirus/isolation & purification ; COVID-19 ; Coronavirus Infections/epidemiology ; Health Personnel/*legislation & jurisprudence ; Humans ; Italy/epidemiology ; *Legislation, Hospital ; *Liability, Legal ; Pandemics/*legislation & jurisprudence ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; },
abstract = {BACKGROUND: On May 12, 2020, a symposium titled "Liability of healthcare professionals and institutions during COVID-19 pandemic" was held in Italy with the participation of national experts in malpractice law, hospital management, legal medicine, and clinical risk management. The symposium's rationale was the highly likely inflation of criminal and civil proceedings concerning alleged errors committed by health care professionals and decision makers during the COVID-19 pandemic. Its aim was to identify and discuss the main issues of legal and medicolegal interest and thus to find solid solutions in the spirit of preparedness planning.

METHODS: There were 5 main points of discussion: (A) how to judge errors committed during the pandemic because of the application of protocols and therapies based on no or weak evidence of efficacy, (B) whether hospital managers can be considered liable for infected health care professionals who were not given adequate personal protective equipment, (C) whether health care professionals and institutions can be considered liable for cases of infected inpatients who claim that the infection was transmitted in a hospital setting, (D) whether health care institutions and hospital managers can be considered liable for the hotspots in long-term care facilities/care homes, and (E) whether health care institutions and hospital managers can be considered liable for the worsening of chronic diseases.

RESULTS AND CONCLUSION: Limitation of the liability to the cases of gross negligence (with an explicit definition of this term), a no-fault system with statal indemnities for infected cases, and a rigorous methodology for the expert witnesses were proposed as key interventions for successfully facing future proceedings.},
}

Betacoronavirus/isolation & purification
COVID-19
Coronavirus Infections/epidemiology
Health Personnel/*legislation & jurisprudence
Humans
Italy/epidemiology
*Legislation, Hospital
*Liability, Legal
Pandemics/*legislation & jurisprudence
Pneumonia, Viral/epidemiology
SARS-CoV-2

@article {pmid32933562,
year = {2020},
author = {Villani, A and Bozzola, E and Staiano, A and Agostiniani, R and Del Vecchio, A and Zamperini, N and Marino, F and Vecchio, D and Corsello, G},
title = {Facial masks in children: the position statement of the Italian pediatric society.},
journal = {Italian journal of pediatrics},
volume = {46},
number = {1},
pages = {132},
pmid = {32933562},
issn = {1824-7288},
mesh = {*Betacoronavirus ; COVID-19 ; Child ; *Consensus ; Coronavirus Infections/epidemiology/*transmission ; Disease Transmission, Infectious/*prevention & control ; Equipment Design ; Humans ; Infection Control/*organization & administration ; Masks/standards/*supply & distribution ; Pandemics ; Pneumonia, Viral/epidemiology/*transmission ; SARS-CoV-2 ; },
abstract = {Facial masks may be one of the most cost-effective strategies to prevent the diffusion of COVID 19 infection. Nevertheless, fake news are spreading, alerting parents on dangerous side effects in children, such as hypercapnia, hypoxia, gut dysbiosis and immune system weakness. Aim of the Italian Pediatric Society statement is to face misconception towards the use of face masks and to spread scientific trustable information.},
}

*Betacoronavirus
COVID-19
Child
*Consensus
Coronavirus Infections/epidemiology/*transmission
Disease Transmission, Infectious/*prevention & control
Equipment Design
Humans
Infection Control/*organization & administration
Masks/standards/*supply & distribution
Pandemics
Pneumonia, Viral/epidemiology/*transmission
SARS-CoV-2

@article {pmid32918548,
year = {2021},
author = {Chiotos, K and Hayes, M and Kimberlin, DW and Jones, SB and James, SH and Pinninti, SG and Yarbrough, A and Abzug, MJ and MacBrayne, CE and Soma, VL and Dulek, DE and Vora, SB and Waghmare, A and Wolf, J and Olivero, R and Grapentine, S and Wattier, RL and Bio, L and Cross, SJ and Dillman, NO and Downes, KJ and Oliveira, CR and Timberlake, K and Young, J and Orscheln, RC and Tamma, PD and Schwenk, HT and Zachariah, P and Aldrich, ML and Goldman, DL and Groves, HE and Rajapakse, NS and Lamb, GS and Tribble, AC and Hersh, AL and Thorell, EA and Denison, MR and Ratner, AJ and Newland, JG and Nakamura, MM},
title = {Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.},
journal = {Journal of the Pediatric Infectious Diseases Society},
volume = {10},
number = {1},
pages = {34-48},
doi = {10.1093/jpids/piaa115},
pmid = {32918548},
issn = {2048-7207},
support = {KL2 TR001862/TR/NCATS NIH HHS/United States ; UL1 TR001863/TR/NCATS NIH HHS/United States ; },
mesh = {Adenosine Monophosphate/analogs & derivatives/therapeutic use ; Alanine/analogs & derivatives/therapeutic use ; Antiviral Agents/*therapeutic use ; COVID-19/therapy/complications ; Child ; Evidence-Based Medicine ; Humans ; Immunocompromised Host ; Risk Factors ; Severity of Illness Index ; Systemic Inflammatory Response Syndrome/drug therapy ; *COVID-19 Drug Treatment ; },
abstract = {BACKGROUND: Although coronavirus disease 2019 (COVID-19) is a mild infection in most children, a small proportion develop severe or critical illness. Data describing agents with potential antiviral activity continue to expand such that updated guidance is needed regarding use of these agents in children.

METHODS: A panel of pediatric infectious diseases physicians and pharmacists from 20 geographically diverse North American institutions was convened. Through a series of teleconferences and web-based surveys, a set of guidance statements was developed and refined based on review of the best available evidence and expert opinion.

RESULTS: Given the typically mild course of COVID-19 in children, supportive care alone is suggested for most cases. For children with severe illness, defined as a supplemental oxygen requirement without need for noninvasive or invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO), remdesivir is suggested, preferably as part of a clinical trial if available. Remdesivir should also be considered for critically ill children requiring invasive or noninvasive mechanical ventilation or ECMO. A duration of 5 days is appropriate for most patients. The panel recommends against the use of hydroxychloroquine or lopinavir-ritonavir (or other protease inhibitors) for COVID-19 in children.

CONCLUSIONS: Antiviral therapy for COVID-19 is not necessary for the great majority of pediatric patients. For children with severe or critical disease, this guidance offers an approach for decision-making regarding use of remdesivir.},
}

Adenosine Monophosphate/analogs & derivatives/therapeutic use
Alanine/analogs & derivatives/therapeutic use
Antiviral Agents/*therapeutic use
COVID-19/therapy/complications
Child
Evidence-Based Medicine
Humans
Immunocompromised Host
Risk Factors
Severity of Illness Index
Systemic Inflammatory Response Syndrome/drug therapy
*COVID-19 Drug Treatment

@article {pmid32890777,
year = {2020},
author = {Greenspan, H and San José Estépar, R and Niessen, WJ and Siegel, E and Nielsen, M},
title = {Position paper on COVID-19 imaging and AI: From the clinical needs and technological challenges to initial AI solutions at the lab and national level towards a new era for AI in healthcare.},
journal = {Medical image analysis},
volume = {66},
number = {},
pages = {101800},
pmid = {32890777},
issn = {1361-8423},
support = {R01 HL149877/HL/NHLBI NIH HHS/United States ; R21 HL140422/HL/NHLBI NIH HHS/United States ; },
mesh = {Algorithms ; Artificial Intelligence/*trends ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/*diagnostic imaging ; Diagnostic Imaging/*methods ; Humans ; Pandemics ; Pneumonia, Viral/*diagnostic imaging ; SARS-CoV-2 ; },
abstract = {In this position paper, we provide a collection of views on the role of AI in the COVID-19 pandemic, from clinical requirements to the design of AI-based systems, to the translation of the developed tools to the clinic. We highlight key factors in designing system solutions - per specific task; as well as design issues in managing the disease at the national level. We focus on three specific use-cases for which AI systems can be built: early disease detection, management in a hospital setting, and building patient-specific predictive models that require the combination of imaging with additional clinical data. Infrastructure considerations and population modeling in two European countries will be described. This pandemic has made the practical and scientific challenges of making AI solutions very explicit. A discussion concludes this paper, with a list of challenges facing the community in the AI road ahead.},
}

Algorithms
Artificial Intelligence/*trends
Betacoronavirus
COVID-19
Coronavirus Infections/*diagnostic imaging
Diagnostic Imaging/*methods
Humans
Pandemics
Pneumonia, Viral/*diagnostic imaging
SARS-CoV-2

@article {pmid32882035,
year = {2020},
author = {Rutkowski, JL and Camm, DP and El Chaar, E},
title = {AAID White Paper: Management of the Dental Implant Patient During the COVID-19 Pandemic and Beyond.},
journal = {The Journal of oral implantology},
volume = {46},
number = {5},
pages = {454-466},
doi = {10.1563/aaid-joi-D-20-00316},
pmid = {32882035},
issn = {0160-6972},
mesh = {*Betacoronavirus ; *COVID-19 ; *Dental Implants ; Humans ; Pandemics ; United States ; },
abstract = {The scientific community's understanding of how the SARS-CoV-2 virus is transmitted and how to best mitigate its spread is improving daily. To help protect patients from acquiring COVID-19 from a dental office nosocomial infection, many state or local governments have classified dental treatments as "nonessential" and have paused routine dental care. Dentists have been instructed to perform only procedures designated as emergencies. Unfortunately, there is not a good understanding of what a dental emergency is among governmental leaders. What a government agency may perceive as an elective procedure may be seen as "essential" by the dental clinician responsible for maintaining the oral health of the patient. Each dental specialty understands the effects delayed care has on a patient's oral and systemic health. Dentistry has made extensive progress in improving oral health through prevention of the dental emergency. The dental profession must work together to prevent the reversal of the progress dentistry and patients have made. This American Academy of Implant Dentistry (AAID) White Paper discusses what COVID-19 is and how it impacts dental treatments, presents guidelines for dentistry in general and for dental implant related treatments, specifically. Recommendations for implant dentistry include the following: (1) what constitutes a dental implant related emergency, (2) how patients should be screened and triaged, (3) what personal protective equipment is necessary, (4) how operatories should be equipped, (5) what equipment should be used, and (6) what, when, and how procedures can be performed. This paper is intended to provide guidance for the dental implant practice so patients and dental health care providers can be safe, and offices can remain open and viable during the pandemic.},
}

*Betacoronavirus
*COVID-19
*Dental Implants
Humans
Pandemics
United States

@article {pmid32876200,
year = {2020},
author = {Soeiro, AM and Leal, TCAT and Pereira, MP and Lima, EG and Figueiredo, ACBDS and Petriz, JLF and Precoma, DB and Serrano, CV},
title = {Position Statement on the Use of Antiplatelet Agents and Anticoagulants in Patients Infected with the New Coronavirus (COVID-19) - 2020.},
journal = {Arquivos brasileiros de cardiologia},
volume = {115},
number = {2},
pages = {292-301},
pmid = {32876200},
issn = {1678-4170},
mesh = {Anticoagulants/*therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/*drug therapy ; Humans ; Pandemics ; Platelet Aggregation Inhibitors/*therapeutic use ; Pneumonia, Viral/*drug therapy ; SARS-CoV-2 ; },
}

Anticoagulants/*therapeutic use
Betacoronavirus
COVID-19
Coronavirus Infections/*drug therapy
Humans
Pandemics
Platelet Aggregation Inhibitors/*therapeutic use
Pneumonia, Viral/*drug therapy
SARS-CoV-2

@article {pmid32871013,
year = {2020},
author = {Noel, JM and Jackson, CW},
title = {ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder.},
journal = {American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
volume = {77},
number = {24},
pages = {2114-2132},
doi = {10.1093/ajhp/zxaa303},
pmid = {32871013},
issn = {1535-2900},
mesh = {Adult ; Antipsychotic Agents/*administration & dosage/adverse effects ; Humans ; Psychotic Disorders/*drug therapy ; Schizophrenia/*drug therapy ; Societies, Pharmaceutical ; United States ; },
abstract = {In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.},
}

Adult
Antipsychotic Agents/*administration & dosage/adverse effects
Humans
Psychotic Disorders/*drug therapy
Schizophrenia/*drug therapy
Societies, Pharmaceutical
United States

@article {pmid32863137,
year = {2020},
author = {Lapid, MI and Seiner, S and Heintz, H and Hermida, AP and Nykamp, L and Sanghani, SN and Mueller, M and Petrides, G and Forester, BP},
title = {Electroconvulsive Therapy Practice Changes in Older Individuals Due to COVID-19: Expert Consensus Statement.},
journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
volume = {28},
number = {11},
pages = {1133-1145},
pmid = {32863137},
issn = {1545-7214},
support = {R01 AG061100/AG/NIA NIH HHS/United States ; },
mesh = {Aged ; Betacoronavirus ; COVID-19 ; Consensus ; *Coronavirus Infections/epidemiology/prevention & control ; *Electroconvulsive Therapy/adverse effects/methods/standards ; Expert Testimony ; Humans ; Infection Control/*methods/organization & administration ; *Mental Disorders/epidemiology/therapy ; *Organizational Innovation ; *Pandemics/prevention & control ; *Pneumonia, Viral/epidemiology/prevention & control ; Practice Guidelines as Topic ; Practice Patterns, Physicians'/*organization & administration ; SARS-CoV-2 ; Systematic Reviews as Topic ; },
abstract = {The ubiquitous coronavirus 2019 (COVID-19) pandemic has required healthcare providers across all disciplines to rapidly adapt to public health guidelines to reduce risk while maintaining quality of care. Electroconvulsive therapy (ECT), which involves an aerosol-generating procedure from manual ventilation with a bag mask valve while under anesthesia, has undergone drastic practice changes in order to minimize disruption of treatment in the midst of COVID-19. In this paper, we provide a consensus statement on the clinical practice changes in ECT specific to older adults based on expert group discussions of ECT practitioners across the country and a systematic review of the literature. There is a universal consensus that ECT is an essential treatment of severe mental illness. In addition, there is a clear consensus on what modifications are imperative to ensure continued delivery of ECT in a manner that is safe for patients and staff, while maintaining the viability of ECT services. Approaches to modifications in ECT to address infection control, altered ECT procedures, and adjusting ECT operations are almost uniform across the globe. With modified ECT procedures, it is possible to continue to meet the needs of older patients while mitigating risk of transmission to this vulnerable population.},
}

Aged
Betacoronavirus
COVID-19
Consensus
*Coronavirus Infections/epidemiology/prevention & control
*Electroconvulsive Therapy/adverse effects/methods/standards
Expert Testimony
Humans
Infection Control/*methods/organization & administration
*Mental Disorders/epidemiology/therapy
*Organizational Innovation
*Pandemics/prevention & control
*Pneumonia, Viral/epidemiology/prevention & control
Practice Guidelines as Topic
Practice Patterns, Physicians'/*organization & administration
SARS-CoV-2
Systematic Reviews as Topic

@article {pmid32859813,
year = {2020},
author = {Deora, H and Sadashiva, N and Tripathi, M and Yagnick, NS and Mohindra, S and Batish, A and Patil, NR and Aggarwal, A and Jangra, K and Bhagat, H and Panda, N and Panigrahi, M and Behari, S and Chandra, PS and Shukla, DP and Singh, L and Math, SB and Gupta, SK},
title = {The Aftermath of COVID-19 Lockdown- Why and How Should We Be Ready?.},
journal = {Neurology India},
volume = {68},
number = {4},
pages = {774-791},
doi = {10.4103/0028-3886.293471},
pmid = {32859813},
issn = {1998-4022},
mesh = {Betacoronavirus/*pathogenicity ; COVID-19 ; Caregivers ; *Consensus ; Coronavirus Infections/*prevention & control/surgery ; Humans ; *Neurosurgery/methods ; Neurosurgical Procedures ; Pandemics/*prevention & control ; Pneumonia, Viral/*prevention & control/surgery ; SARS-CoV-2 ; },
abstract = {INTRODUCTION: Severe acute respiratory syndrome, coronavirus 2 (SARS-COV 2) has inexplicably and irreversibly changed the way of neurosurgery practice. There has been a substantial reduction in neurosurgical operations during the period of lockdown. The lockdown might be the most effective measure to curtail viral transmission. Once we return to the normalization of the lifestyle, there will be a backlog of unoperated pending cases along with the possibility of further spread of the coronavirus.

METHODS: We reviewed the available literature and protocols for neurosurgical practice in different geographic locations. We drafted a consensus statement based on the literature and protocols suggested by the World Health Organization (WHO) and various professional societies to prevent the spread of SARS-COV2 while streamlining the neurosurgical practice.

RESULTS: The consensus statement suggests the patient triage, workflow, resource distribution, and operational efficacy for care providers at different stages of management. The priority is set at personal protection while ensuring patients' safety, timely management, and capacity building. We performed a detailed subsection analysis for the management of trauma and set up for COVID-free hospitals for simultaneous management of routine neurosurgical indications. In this time of medicolegal upheaval, special consent from the patients should be taken in view of the chances of delay in management and the added risk of corona infection. The consensus statements are applicable to neurosurgical setups of all capacities.

CONCLUSION: Along with the glaring problem of infection, there is another threat of neurosurgery emergency building up. This wave may overwhelm the already stretched systems to the hilt. We need to flatten this curve while avoiding contagion. These measures may guide neurosurgery practitioners to effectively manage patients ensuring the safety of caregivers and care seekers both.},
}

Betacoronavirus/*pathogenicity
COVID-19
Caregivers
*Consensus
Coronavirus Infections/*prevention & control/surgery
Humans
*Neurosurgery/methods
Neurosurgical Procedures
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control/surgery
SARS-CoV-2

@article {pmid32852385,
year = {2020},
author = {Yang, XH and Hu, B and Shang, Y and Liu, J and Zhong, M and Shang, XL and Wu, ZX and Yu, Z and Sun, RH and Wang, HL and Zhao, MY and Meng, M and Xu, QH and Zheng, X and Chen, DC},
title = {Expert consensus on management of analgesia and sedation for patients with severe coronavirus disease 2019.},
journal = {Chinese medical journal},
volume = {133},
number = {18},
pages = {2186-2188},
doi = {10.1097/CM9.0000000000001034},
pmid = {32852385},
issn = {2542-5641},
mesh = {Analgesia/*methods ; *Betacoronavirus ; COVID-19 ; Procedural Sedation/*methods ; Consensus ; Coronavirus Infections/*complications ; Humans ; Pandemics ; Pneumonia, Viral/*complications ; SARS-CoV-2 ; },
}

Analgesia/*methods
*Betacoronavirus
COVID-19
Procedural Sedation/*methods
Consensus
Coronavirus Infections/*complications
Humans
Pandemics
Pneumonia, Viral/*complications
SARS-CoV-2

@article {pmid32825892,
year = {2020},
author = {Vora, A and Arora, VK and Behera, D and Tripathy, SK},
title = {White paper on Ivermectin as a potential therapy for COVID-19.},
journal = {The Indian journal of tuberculosis},
volume = {67},
number = {3},
pages = {448-451},
pmid = {32825892},
issn = {0019-5707},
mesh = {Antiparasitic Agents/therapeutic use ; *Betacoronavirus ; COVID-19 ; Coronavirus Infections/*drug therapy ; Humans ; Ivermectin/*therapeutic use ; Pandemics ; Pneumonia, Viral/*drug therapy ; Risk Factors ; SARS-CoV-2 ; Treatment Outcome ; },
abstract = {A group of senior doctors with vast clinical experience met on 19th July'20 under the aegis of Academy of Advanced Medical Education. The panel looked at Ivermectin, one of the old molecule and evaluated it's use in COVID 19 (Novel Coronavirus Disease 2019) management. After critical panel discussion, all the attending doctors came to a conclusion that Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with Coronavirus, owing to its anti-viral properties coupled with effective cost, availability and good tolerability and safety.},
}

Antiparasitic Agents/therapeutic use
*Betacoronavirus
COVID-19
Coronavirus Infections/*drug therapy
Humans
Ivermectin/*therapeutic use
Pandemics
Pneumonia, Viral/*drug therapy
Risk Factors
SARS-CoV-2
Treatment Outcome

@article {pmid32823368,
year = {2020},
author = {Pfaar, O and Klimek, L and Worm, M and Bergmann, KC and Bieber, T and Buhl, R and Buters, J and Darsow, U and Keil, T and Kleine-Tebbe, J and Lau, S and Maurer, M and Merk, H and Mösges, R and Saloga, J and Staubach, P and Stute, P and Rabe, K and Rabe, U and Vogelmeier, C and Biedermann, T and Jung, K and Schlenter, W and Ring, J and Chaker, A and Wehrmann, W and Becker, S and Mülleneisen, N and Nemat, K and Czech, W and Wrede, H and Brehler, R and Fuchs, T and Tomazic, PV and Aberer, W and Fink-Wagner, A and Horak, F and Wöhrl, S and Niederberger-Leppin, V and Pali-Schöll, I and Pohl, W and Roller-Wirnsberger, R and Spranger, O and Valenta, R and Akdis, M and Akdis, C and Hoffmann-Sommergruber, K and Jutel, M and Matricardi, P and Spertini, F and Khaltaev, N and Michel, JP and Nicod, L and Schmid-Grendelmeier, P and Hamelmann, E and Jakob, T and Werfel, T and Wagenmann, M and Taube, C and Gerstlauer, M and Vogelberg, C and Bousquet, J and Zuberbier, T},
title = {[Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)].},
journal = {Laryngo- rhino- otologie},
volume = {99},
number = {10},
pages = {676-679},
doi = {10.1055/a-1170-8426},
pmid = {32823368},
issn = {1438-8685},
mesh = {*Betacoronavirus ; COVID-19 ; *Coronavirus Infections ; Desensitization, Immunologic ; Humans ; *Pandemics ; *Pneumonia, Viral ; SARS-CoV-2 ; },
}

*Betacoronavirus
COVID-19
*Coronavirus Infections
Desensitization, Immunologic
Humans
*Pandemics
*Pneumonia, Viral
SARS-CoV-2

@article {pmid32809121,
year = {2020},
author = {Kort, NP and Barrena, EG and Bédard, M and Donell, S and Epinette, JA and Gomberg, B and Hirschmann, MT and Indelli, P and Khosravi, I and Karachalios, T and Liebensteiner, MC and Stuyts, B and Tandogan, R and Violante, B and Zagra, L and Thaler, M},
title = {Recommendations for resuming elective hip and knee arthroplasty in the setting of the SARS-CoV-2 pandemic: the European Hip Society and European Knee Associates Survey of Members.},
journal = {Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA},
volume = {28},
number = {9},
pages = {2723-2729},
pmid = {32809121},
issn = {1433-7347},
mesh = {*Arthroplasty, Replacement, Hip ; *Arthroplasty, Replacement, Knee ; Betacoronavirus ; COVID-19 ; Consensus ; Coronavirus Infections/*epidemiology ; Delivery of Health Care/*methods ; Elective Surgical Procedures/*methods ; Europe ; Humans ; Orthopedic Surgeons ; Pandemics ; Pneumonia, Viral/*epidemiology ; *Practice Guidelines as Topic ; Prospective Studies ; SARS-CoV-2 ; Surveys and Questionnaires ; },
abstract = {PURPOSE: The COVID-19 pandemic has disrupted the health care system around the entire globe. A consensus is needed about resuming total hip and knee procedures. The European Hip Society (EHS) and the European Knee Association (EKA) formed a panel of experts that have produced a consensus statement on how the safe re-introduction of elective hip and knee arthroplasty should be undertaken.

METHODS: A prospective online survey was done among members of EHS and EKA. The survey consisted of 27 questions. It includes basic information on demographics and details the participant's agreement with each recommendation. The participant could choose among three options (agree, disagree, abstain). Recommendations focussed on pre-operative, peri-operative, and post-operative handling of patients and precautions.

RESULTS: A total of 681 arthroplasty surgeons participated in the survey, with 479 fully completing the survey. The participants were from 44 countries and 6 continents. Apart from adhering to National and Local Guidelines, the recommendations concerned how to make elective arthroplasty safe for patients and staff.

CONCLUSION: The survey has shown good-to-excellent agreement of the participants with regards to the statements made in the recommendations for the safe return to elective arthroplasty following the first wave of the COVID-19 pandemic.},
}

*Arthroplasty, Replacement, Hip
*Arthroplasty, Replacement, Knee
Betacoronavirus
COVID-19
Consensus
Coronavirus Infections/*epidemiology
Delivery of Health Care/*methods
Elective Surgical Procedures/*methods
Europe
Humans
Orthopedic Surgeons
Pandemics
Pneumonia, Viral/*epidemiology
*Practice Guidelines as Topic
Prospective Studies
SARS-CoV-2
Surveys and Questionnaires

@article {pmid32794674,
year = {2020},
author = {Bone Circulation And Osteonecrosis Professional Committee Shockwave Medical Specialty Committee Of Chinese Research Hospital Association, },
title = {[Expert consensus on prevention and treatment strategies for osteonecrosis of femoral head during the prevention and control of novel coronavirus pneumonia (2020)].},
journal = {Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery},
volume = {34},
number = {8},
pages = {1031-1035},
pmid = {32794674},
issn = {1002-1892},
mesh = {Betacoronavirus ; COVID-19 ; Consensus ; Coronavirus Infections/*epidemiology ; Femur Head/pathology ; Femur Head Necrosis/*prevention & control/*therapy ; Humans ; Osteonecrosis/*prevention & control/*therapy ; Pandemics ; Pneumonia, Viral/*epidemiology ; SARS-CoV-2 ; },
abstract = {Novel coronavirus pneumonia is a new type of respiratory infectious disease that has rapidly spread in many countries or regions around the world. The World Health Organization (WHO) named it "coronavirus disease 2019 (COVID-19)". Glucocorticoids (GC) have certain application value in patients with COVID-19, but they need to be used with caution and strict indications and dosage. Application of large doses of GC can also cause osteonecrosis of femoral head (ONFH). On the basis of the latest literature and evidence-based medical evidence on the fight against COVID-19 epidemic and steroid ONFH diagnosis and treatment, the Bone Circulation and Osteonecrosis Professional Committee, Shockwave Medical Specialty Committee of Chinese Research Hospital Association organized Chinese bone necrosis related experts to jointly write this consensus, focusing on the prevention strategy and the protective management measures in the ONFH diagnosis and treatment process during the prevention and control of COVID-19, which can provide reference for hospitals at all levels to carry out early prevention and treatment of ONFH.},
}

Betacoronavirus
COVID-19
Consensus
Coronavirus Infections/*epidemiology
Femur Head/pathology
Femur Head Necrosis/*prevention & control/*therapy
Humans
Osteonecrosis/*prevention & control/*therapy
Pandemics
Pneumonia, Viral/*epidemiology
SARS-CoV-2

@article {pmid32754159,
year = {2020},
author = {Bhaskar, S and Sinha, A and Banach, M and Mittoo, S and Weissert, R and Kass, JS and Rajagopal, S and Pai, AR and Kutty, S},
title = {Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.},
journal = {Frontiers in immunology},
volume = {11},
number = {},
pages = {1648},
pmid = {32754159},
issn = {1664-3224},
support = {001/WHO_/World Health Organization/International ; },
mesh = {Adrenal Cortex Hormones/therapeutic use ; Angiotensin-Converting Enzyme 2 ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Betacoronavirus/*immunology ; CD4-CD8 Ratio ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; COVID-19 ; Clinical Decision-Making/methods ; Coronavirus Infections/blood/*drug therapy/*immunology/mortality ; Critical Care/*methods ; Critical Illness ; Cytokines/*blood ; Endothelial Cells/metabolism ; Female ; Humans ; Immunocompromised Host ; Janus Kinase Inhibitors/therapeutic use ; Male ; Pandemics ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/blood/*drug therapy/*immunology/mortality ; SARS-CoV-2 ; Sex Factors ; Thrombosis ; Interleukin-6 Inhibitors ; Interleukin-6 ; },
abstract = {Cytokine storm is an acute hyperinflammatory response that may be responsible for critical illness in many conditions including viral infections, cancer, sepsis, and multi-organ failure. The phenomenon has been implicated in critically ill patients infected with SARS-CoV-2, the novel coronavirus implicated in COVID-19. Critically ill COVID-19 patients experiencing cytokine storm are believed to have a worse prognosis and increased fatality rate. In SARS-CoV-2 infected patients, cytokine storm appears important to the pathogenesis of several severe manifestations of COVID-19: acute respiratory distress syndrome, thromboembolic diseases such as acute ischemic strokes caused by large vessel occlusion and myocardial infarction, encephalitis, acute kidney injury, and vasculitis (Kawasaki-like syndrome in children and renal vasculitis in adult). Understanding the pathogenesis of cytokine storm will help unravel not only risk factors for the condition but also therapeutic strategies to modulate the immune response and deliver improved outcomes in COVID-19 patients at high risk for severe disease. In this article, we present an overview of the cytokine storm and its implications in COVID-19 settings and identify potential pathways or biomarkers that could be targeted for therapy. Leveraging expert opinion, emerging evidence, and a case-based approach, this position paper provides critical insights on cytokine storm from both a prognostic and therapeutic standpoint.},
}

Adrenal Cortex Hormones/therapeutic use
Angiotensin-Converting Enzyme 2
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
Betacoronavirus/*immunology
CD4-CD8 Ratio
CD4-Positive T-Lymphocytes/immunology
CD8-Positive T-Lymphocytes/immunology
COVID-19
Clinical Decision-Making/methods
Coronavirus Infections/blood/*drug therapy/*immunology/mortality
Critical Care/*methods
Critical Illness
Cytokines/*blood
Endothelial Cells/metabolism
Female
Humans
Immunocompromised Host
Janus Kinase Inhibitors/therapeutic use
Male
Pandemics
Peptidyl-Dipeptidase A/metabolism
Pneumonia, Viral/blood/*drug therapy/*immunology/mortality
SARS-CoV-2
Sex Factors
Thrombosis
Interleukin-6 Inhibitors
Interleukin-6

@article {pmid32748068,
year = {2020},
author = {Stolbach, A and Mazer-Amirshahi, M and Schwarz, ES and Juurlink, D and Wiegand, TJ and Nelson, LS},
title = {ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic.},
journal = {Journal of medical toxicology : official journal of the American College of Medical Toxicology},
volume = {16},
number = {4},
pages = {484-486},
pmid = {32748068},
issn = {1937-6995},
mesh = {*Betacoronavirus ; COVID-19 ; Coronavirus Infections/*epidemiology ; Health Services Accessibility ; Humans ; Opioid-Related Disorders/*therapy ; Pandemics ; Pneumonia, Viral/*epidemiology ; SARS-CoV-2 ; Toxicology ; },
}

*Betacoronavirus
COVID-19
Coronavirus Infections/*epidemiology
Health Services Accessibility
Humans
Opioid-Related Disorders/*therapy
Pandemics
Pneumonia, Viral/*epidemiology
SARS-CoV-2
Toxicology

@article {pmid32740826,
year = {2021},
author = {Pouwels, S and Omar, I and Aggarwal, S and Aminian, A and Angrisani, L and Balibrea, JM and Bhandari, M and Biter, LU and Blackstone, RP and Carbajo, MA and Copaescu, CA and Dargent, J and Elfawal, MH and Fobi, MA and Greve, JW and Hazebroek, EJ and Herrera, MF and Himpens, JM and Hussain, FA and Kassir, R and Kerrigan, D and Khaitan, M and Kow, L and Kristinsson, J and Kurian, M and Lutfi, RE and Moore, RL and Noel, P and Ozmen, MM and Ponce, J and Prager, G and Purkayastha, S and Rafols, JP and Ramos, AC and Ribeiro, RJS and Sakran, N and Salminen, P and Shabbir, A and Shikora, SA and Singhal, R and Small, PK and Taylor, CJ and Torres, AJ and Vaz, C and Yashkov, Y and Mahawar, K},
title = {The First Modified Delphi Consensus Statement for Resuming Bariatric and Metabolic Surgery in the COVID-19 Times.},
journal = {Obesity surgery},
volume = {31},
number = {1},
pages = {451-456},
pmid = {32740826},
issn = {1708-0428},
mesh = {*Bariatric Surgery ; *COVID-19 ; Consensus ; Delphi Technique ; Humans ; Obesity, Morbid/surgery ; Pandemics ; SARS-CoV-2 ; },
abstract = {The purpose of this study was to achieve consensus amongst a global panel of expert bariatric surgeons on various aspects of resuming Bariatric and Metabolic Surgery (BMS) during the Coronavirus Disease-2019 (COVID-19) pandemic. A modified Delphi consensus-building protocol was used to build consensus amongst 44 globally recognised bariatric surgeons. The experts were asked to either agree or disagree with 111 statements they collectively proposed over two separate rounds. An agreement amongst ≥ 70.0% of experts was construed as consensus as per the predetermined methodology. We present here 38 of our key recommendations. This first global consensus statement on the resumption of BMS can provide a framework for multidisciplinary BMS teams planning to resume local services as well as guide future research in this area.},
}

*Bariatric Surgery
*COVID-19
Consensus
Delphi Technique
Humans
Obesity, Morbid/surgery
Pandemics
SARS-CoV-2

@article {pmid32740024,
year = {2020},
author = {Maculotti, D and Spena, PR and Villa, G},
title = {POSITION STATEMENT ON CARE OF OSTOMY PATIENTS DURING COVID-19 PANDEMIC.},
journal = {Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates},
volume = {43},
number = {4},
pages = {324-326},
doi = {10.1097/SGA.0000000000000539},
pmid = {32740024},
issn = {1538-9766},
mesh = {Ambulatory Care ; *Betacoronavirus ; COVID-19 ; Coronavirus Infections/*epidemiology/prevention & control/transmission ; Hospitalization ; Humans ; Infection Control/*organization & administration ; *Ostomy ; Pandemics/prevention & control ; Patient Selection ; Pneumonia, Viral/*epidemiology/prevention & control/transmission ; SARS-CoV-2 ; },
}

Ambulatory Care
*Betacoronavirus
COVID-19
Coronavirus Infections/*epidemiology/prevention & control/transmission
Hospitalization
Humans
Infection Control/*organization & administration
*Ostomy
Pandemics/prevention & control
Patient Selection
Pneumonia, Viral/*epidemiology/prevention & control/transmission
SARS-CoV-2

@article {pmid32732509,
year = {2020},
author = {Moore, TA},
title = {Overview of the Care of Mothers and Newborns With COVID-19; Joint Position Statement.},
journal = {Advances in neonatal care : official journal of the National Association of Neonatal Nurses},
volume = {20},
number = {4},
pages = {268},
pmid = {32732509},
issn = {1536-0911},
mesh = {American Nurses' Association ; Betacoronavirus ; COVID-19 ; *Coronavirus Infections/epidemiology/prevention & control ; *Evidence-Based Nursing/methods/trends ; Female ; Humans ; Infant, Newborn ; Infection Control/organization & administration ; *Neonatal Nursing/organization & administration/standards ; Organizational Innovation ; *Pandemics/prevention & control ; *Pneumonia, Viral/epidemiology/prevention & control ; *Postnatal Care/methods/organization & administration/trends ; SARS-CoV-2 ; United States ; },
}

American Nurses' Association
Betacoronavirus
COVID-19
*Coronavirus Infections/epidemiology/prevention & control
*Evidence-Based Nursing/methods/trends
Female
Humans
Infant, Newborn
Infection Control/organization & administration
*Neonatal Nursing/organization & administration/standards
Organizational Innovation
*Pandemics/prevention & control
*Pneumonia, Viral/epidemiology/prevention & control
*Postnatal Care/methods/organization & administration/trends
SARS-CoV-2
United States

@article {pmid32720374,
year = {2020},
author = {Tay, EL and Hayashida, K and Chen, M and Yin, WH and Park, DW and Seth, A and Kao, HL and Lin, MS and Ho, KW and Buddhari, W and Chandavimol, M and Posas, FE and Nguyen, QN and Kong, W and Rosli, MA and Hon, J and Firman, D and Lee, M},
title = {Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia.},
journal = {Journal of cardiac surgery},
volume = {35},
number = {9},
pages = {2142-2146},
doi = {10.1111/jocs.14722},
pmid = {32720374},
issn = {1540-8191},
mesh = {Aortic Valve Stenosis/surgery ; Asia/epidemiology ; COVID-19/*epidemiology/prevention & control ; COVID-19 Testing ; Humans ; Infection Control/standards ; Infectious Disease Transmission, Patient-to-Professional/prevention & control ; Length of Stay/trends ; Pandemics ; Preoperative Care/*standards ; Remote Consultation ; Surveys and Questionnaires ; Transcatheter Aortic Valve Replacement/*standards ; Triage ; },
abstract = {OBJECTIVES: The impact of the COVID-19 pandemic on the treatment of patient with aortic valve stenosis is unknown and there is uncertainty on the optimal strategies in managing these patients.

METHODS: This study is supported and endorsed by the Asia Pacific Society of Interventional Cardiology. Due to the inability to have face to face discussions during the pandemic, an online survey was performed by inviting key opinion leaders (cardiac surgeon/interventional cardiologist/echocardiologist) in the field of transcatheter aortic valve implantation (TAVI) in Asia to participate. The answers to a series of questions pertaining to the impact of COVID-19 on TAVI were collected and analyzed. These led subsequently to an expert consensus recommendation on the conduct of TAVI during the pandemic.

RESULTS: The COVID-19 pandemic had resulted in a 25% (10-80) reduction of case volume and 53% of operators required triaging to manage their patients with severe aortic stenosis. The two most important parameters used to triage were symptoms and valve area. Periprocedural changes included the introduction of teleconsultation, preprocedure COVID-19 testing, optimization of protests, and catheterization laboratory set up. In addition, length of stay was reduced from a mean of 4.4 to 4 days.

CONCLUSION: The COVID-19 pandemic has impacted on the delivery of TAVI services to patients in Asia. This expert recommendation on best practices may be a useful guide to help TAVI teams during this period until a COVID-19 vaccine becomes widely available.},
}

Aortic Valve Stenosis/surgery
Asia/epidemiology
COVID-19/*epidemiology/prevention & control
COVID-19 Testing
Humans
Infection Control/standards
Infectious Disease Transmission, Patient-to-Professional/prevention & control
Length of Stay/trends
Pandemics
Preoperative Care/*standards
Remote Consultation
Surveys and Questionnaires
Transcatheter Aortic Valve Replacement/*standards
Triage

@article {pmid32719884,
year = {2020},
author = {Gutenbrunner, C and Stokes, EK and Dreinhöfer, K and Monsbakken, J and Clarke, S and Côté, P and Urseau, I and Constantine, D and Tardif, C and Balakrishna, V and Nugraha, B},
title = {Why Rehabilitation must have priority during and after the COVID-19-pandemic: A position statement of the Global Rehabilitation Alliance.},
journal = {Journal of rehabilitation medicine},
volume = {52},
number = {7},
pages = {jrm00081},
doi = {10.2340/16501977-2713},
pmid = {32719884},
issn = {1651-2081},
mesh = {*Betacoronavirus ; COVID-19 ; Coronavirus Infections/prevention & control/*rehabilitation ; Global Health ; Health Services Accessibility/standards ; Humans ; Infection Control/standards ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control/*rehabilitation ; SARS-CoV-2 ; },
abstract = {COVID-19 has become a pandemic with strong influence on health systems. In many cases it leads to a disruption of rehabilitation service provision. On the other hand, rehabilitation must be an integral part of COVID-19 management. Rehabilitation for COVID-19 should start from acute and early post-acute care and needs to be continued in the post-acute and long-term rehabilitation phase. Of course, it should follow specific safety protocol. Additionally, rehabilitation must be kept available for all other people who are in need. From the perspective of health system, the Global Rehabilitation Alliance urges decision makers to ensure that rehabilitation services will be available for all patients with COVID-19 in the acute, post-acute and long-term phase. Additionally, it must be ensured that all other persons with rehabilitation need have access to rehabilitation services. Rehabilitation services must be equipped with personal protection equipment and follow strict hygiene measures. In particular, rehabilitation must be accessible for vulnerable populations. For that reason, rehabilitation must be kept a health priority during the COVID-19 pandemic and given adequate financial resources. Last but not least, scientific studies should be performed to clarify the impact of the pandemic on rehabilitation services as well as on the needs for rehabilitation of COVID-19 patients.},
}

*Betacoronavirus
COVID-19
Coronavirus Infections/prevention & control/*rehabilitation
Global Health
Health Services Accessibility/standards
Humans
Infection Control/standards
Pandemics/prevention & control
Pneumonia, Viral/prevention & control/*rehabilitation
SARS-CoV-2

@article {pmid32694078,
year = {2020},
author = {Vivas, D and Roldán, V and Esteve-Pastor, MA and Roldán, I and Tello-Montoliu, A and Ruiz-Nodar, JM and Cosín-Sales, J and Gámez, JM and Consuegra, L and Ferreiro, JL and Marín, F and , },
title = {Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology.},
journal = {Revista espanola de cardiologia (English ed.)},
volume = {73},
number = {9},
pages = {749-757},
pmid = {32694078},
issn = {1885-5857},
mesh = {*Betacoronavirus ; COVID-19 ; Cardiology ; Coronavirus Infections/*drug therapy ; Fibrinolytic Agents/*therapeutic use ; Humans ; Pandemics ; Patient Selection ; Pneumonia, Viral/*drug therapy ; SARS-CoV-2 ; Societies, Medical ; Spain ; COVID-19 Drug Treatment ; },
abstract = {The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is very scarce information on the management of thrombotic risk, coagulation disorders, and anticoagulant therapy. In addition, the situation has also greatly influenced usual care in patients not infected with COVID-19. This article by the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology aims to summarize the available information and to provide a practical approach to the management of antithrombotic therapy.},
}

*Betacoronavirus
COVID-19
Cardiology
Coronavirus Infections/*drug therapy
Fibrinolytic Agents/*therapeutic use
Humans
Pandemics
Patient Selection
Pneumonia, Viral/*drug therapy
SARS-CoV-2
Societies, Medical
Spain
COVID-19 Drug Treatment

@article {pmid32690158,
year = {2020},
author = {Matras, P and Klek, S and Folwarski, M and Zmarzly, A and Bartoszewska, L and Cebulski, W and Jakubczyk, M and Kamocki, Z and Klepczyk, K and Kunecki, M and Lawiński, M and Majewska, K and Matczuk, M and Matysiak-Lusnia, K and Sadowski, M and Sobocki, J and Sumlet, M and Szafranski, W and Szczepanek, K and Urbanowicz, K and Zoubek-Wojcik, A},
title = {Home medical nutrition during SARS-CoV-2 pandemic - A position paper.},
journal = {Clinical nutrition ESPEN},
volume = {38},
number = {},
pages = {196-200},
pmid = {32690158},
issn = {2405-4577},
mesh = {*Betacoronavirus ; COVID-19 ; COVID-19 Testing ; Caregivers/education ; Clinical Laboratory Techniques ; Consensus ; Coronavirus Infections/*complications/diagnosis/prevention & control ; Delivery of Health Care ; Enteral Nutrition/*methods ; *Home Care Services ; Humans ; Infectious Disease Transmission, Patient-to-Professional/prevention & control ; Pandemics/prevention & control ; Parenteral Nutrition/*methods ; Patient Care Team ; Patient Isolation ; Patient-Centered Care/methods ; Personal Protective Equipment ; Pneumonia, Viral/*complications/diagnosis/prevention & control ; Risk Factors ; SARS-CoV-2 ; },
abstract = {BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a worldwide rapidly spreading illness, Coronavirus Disease 2019 (COVID-19). Patients fed enterally and parenterally at home are exposed to the same risk of infection as the general population, but more prone to complications than others. Therefore the guidance for care-givers and care-takers of these patients is needed.

METHODS: The literature search identified no relevant systematic reviews or studies on the subject. Therefore a panel of 21 experts from 13 home medical nutrition (HMN) centres in Poland was formed. Twenty-three key issues relevant to the management of SARS-CoV-2 infection or COVID-19 in the HMN settings were identified and discussed. Some statements diverge from the available nutrition, surgical or ICU guidelines, some are based on the best available experience. Each topic was discussed and assessed during two Delphi rounds subsequently. Statements were graded strong or weak based on the balance between benefit and harm, resource and cost implications, equity, and feasibility.

RESULTS: the panel issued 23 statements, all of them were graded strong. Two scored 85.71% agreement, eleven 95.23%, and ten 100%. The topics were: infection control, enrolment to HMN, logistics and patient information.

CONCLUSIONS: the position paper present pragmatic statements for HMN to be implemented in places without existing protocols for SARS-CoV-2 pandemic. They represent the state of knowledge available at the moment and may change should new evidence occurs.},
}

*Betacoronavirus
COVID-19
COVID-19 Testing
Caregivers/education
Clinical Laboratory Techniques
Consensus
Coronavirus Infections/*complications/diagnosis/prevention & control
Delivery of Health Care
Enteral Nutrition/*methods
*Home Care Services
Humans
Infectious Disease Transmission, Patient-to-Professional/prevention & control
Pandemics/prevention & control
Parenteral Nutrition/*methods
Patient Care Team
Patient Isolation
Patient-Centered Care/methods
Personal Protective Equipment
Pneumonia, Viral/*complications/diagnosis/prevention & control
Risk Factors
SARS-CoV-2

@article {pmid32683408,
year = {2020},
author = {Alghamdi, F and Alshaikh, N and Bamaga, AK and Bashiri, FA and Hundullah, K and Alshehri, A and Al-Muhaizea, MA and Al-Saman, A},
title = {A consensus statement on spinal muscular atrophy management in Saudi Arabia in the context of COVID-19.},
journal = {Neurosciences (Riyadh, Saudi Arabia)},
volume = {25},
number = {3},
pages = {230-237},
pmid = {32683408},
issn = {1319-6138},
mesh = {*Betacoronavirus ; COVID-19 ; Consensus ; Coronavirus Infections/*complications/epidemiology ; *Disease Management ; Humans ; Muscular Atrophy, Spinal/*complications/*therapy ; Pandemics ; Pneumonia, Viral/*complications/epidemiology ; SARS-CoV-2 ; Saudi Arabia/epidemiology ; },
}

*Betacoronavirus
COVID-19
Consensus
Coronavirus Infections/*complications/epidemiology
*Disease Management
Humans
Muscular Atrophy, Spinal/*complications/*therapy
Pandemics
Pneumonia, Viral/*complications/epidemiology
SARS-CoV-2
Saudi Arabia/epidemiology

@article {pmid32675009,
year = {2020},
author = {Torlone, E and Festa, C and Formoso, G and Scavini, M and Sculli, MA and Succurro, E and Sciacca, L and Di Bartolo, P and Purrello, F and Lapolla, A},
title = {Italian recommendations for the diagnosis of gestational diabetes during COVID-19 pandemic: Position statement of the Italian Association of Clinical Diabetologists (AMD) and the Italian Diabetes Society (SID), diabetes, and pregnancy study group.},
journal = {Nutrition, metabolism, and cardiovascular diseases : NMCD},
volume = {30},
number = {9},
pages = {1418-1422},
pmid = {32675009},
issn = {1590-3729},
mesh = {*Betacoronavirus ; Blood Glucose/analysis ; COVID-19 ; Coronavirus Infections/*epidemiology ; Diabetes, Gestational/*diagnosis ; Female ; Glucose Tolerance Test ; Humans ; Italy ; Pandemics ; Pneumonia, Viral/*epidemiology ; Pregnancy ; SARS-CoV-2 ; },
abstract = {AIM: In response to the COVID-19 pandemic, there is a need for substantial changes in the procedures for accessing healthcare services. Even in the current pandemic, we should not reduce our attention towards the diagnosis and treatment of GDM. The purpose of this document is to provide a temporary guide for GDM screening, replacing the current guidelines when it is not possible to implement standard GDM screening because of an unfavorable risk/benefit ratio for pregnant women or when usual laboratory facilities are not available.

DATA SYNTHESIS: At the first visit during pregnancy, we must exclude the presence of "Overt diabetes" in all women. The criteria for the diagnosis of overt diabetes are either fasting plasma glucose ≥126 mg/dL, or random plasma glucose ≥200 mg/dL, or glycated hemoglobin ≥6.5%. When the screening procedure (OGTT) cannot be safely performed, the diagnosis of GDM is acceptable if fasting plasma glucose is ≥ 92 mg/dL. In order to consider the impaired fasting glucose as an acceptable surrogate for the diagnosis of GDM, the fasting glucose measurement should be performed within the recommended time windows for the risk level (high or medium risk).

CONCLUSIONS: The changes to the screening procedure for GDM reported below are specifically produced in response to the health emergency of the COVID-19 pandemic. Therefore, these recommended changes should cease to be in effect and should be replaced by current national guidelines when the healthcare authorities declare the end of this emergency.},
}

*Betacoronavirus
Blood Glucose/analysis
COVID-19
Coronavirus Infections/*epidemiology
Diabetes, Gestational/*diagnosis
Female
Glucose Tolerance Test
Humans
Italy
Pandemics
Pneumonia, Viral/*epidemiology
Pregnancy
SARS-CoV-2

@article {pmid32674177,
year = {2020},
author = {Kolditz, M and Dellweg, D and Geerdes-Fenge, H and Lepper, PM and Schaberg, T and Ewig, S and Pfeifer, M and Bauer, T},
title = {[Treatment with Dexamethasone in Patients with COVID-19 - A Position Paper of the German Respiratory Society (DGP)].},
journal = {Pneumologie (Stuttgart, Germany)},
volume = {74},
number = {8},
pages = {493-495},
pmid = {32674177},
issn = {1438-8790},
mesh = {Anti-Inflammatory Agents/*therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus/*isolation & purification ; Coronavirus Infections/diagnosis/*drug therapy ; Dexamethasone/*therapeutic use ; Germany ; Humans ; *Pandemics ; Pneumonia, Viral/diagnosis/*drug therapy ; *Practice Guidelines as Topic ; SARS-CoV-2 ; Societies, Medical ; Treatment Outcome ; COVID-19 Drug Treatment ; },
}

Anti-Inflammatory Agents/*therapeutic use
Betacoronavirus
COVID-19
Coronavirus/*isolation & purification
Coronavirus Infections/diagnosis/*drug therapy
Dexamethasone/*therapeutic use
Germany
Humans
*Pandemics
Pneumonia, Viral/diagnosis/*drug therapy
*Practice Guidelines as Topic
SARS-CoV-2
Societies, Medical
Treatment Outcome
COVID-19 Drug Treatment

@article {pmid32669938,
year = {2020},
author = {Blais, N and Bouchard, M and Chinas, M and Lizotte, H and Morneau, M and Spicer, J and Martel, S},
title = {Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemic.},
journal = {Current oncology (Toronto, Ont.)},
volume = {27},
number = {3},
pages = {e313-e317},
pmid = {32669938},
issn = {1718-7729},
mesh = {Administration, Oral ; Antineoplastic Agents/*administration & dosage/therapeutic use ; Betacoronavirus ; COVID-19 ; Carcinoma, Non-Small-Cell Lung/diagnosis/*therapy ; Coronavirus Infections/*epidemiology ; Disease Management ; Humans ; Lung Neoplasms/diagnosis/*therapy ; Mediastinoscopy ; Medical Oncology ; Molecular Diagnostic Techniques ; Neoplasm Staging ; Pandemics ; Pneumonia, Viral/*epidemiology ; Quebec/epidemiology ; Radiosurgery ; *Radiotherapy ; SARS-CoV-2 ; Small Cell Lung Carcinoma/diagnosis/*therapy ; *Thoracic Surgical Procedures ; Thoracoscopy ; *Triage ; },
abstract = {BACKGROUND: The emergence of covid-19 has the potential to change the way in which the health care system can accommodate various patient populations and might affect patients with non-covid-19 problems. The Quebec Lung Cancer Network, which oversees thoracic oncology services in the province of Quebec under the direction of the Ministère de la Santé et des Services sociaux, convened to develop recommendations to deal with the potential disruption of services in thoracic oncology in the province of Quebec. The summary provided here has been adapted from the original document posted on the Programme québécois du cancer Web site at: https://www.msss.gouv.qc.ca/professionnels/documents/coronavirus-2019-ncov/PJ1_Recommandations_oncologie-thoracique-200415.pdf.

METHODS: Plans to optimize the health care system and potentially to prioritize services were discussed with respect to various levels of activity. For each level-of-activity scenario, suggestions were made for the services and treatments to prioritize and for those that might have to be postponed, as well as for potential alternatives to care.

RESULTS: The principal recommendation is that the cancer centre executive committee and the multidisciplinary tumour board always try to find a solution to maintain standard-of-care therapy for all patients with thoracic tumours, using novel approaches to treatment and the adoption of a network approach to care, as needed.

CONCLUSIONS: The effect of the covid-19 pandemic on the health care system remains unpredictable and requires that cancer teams unite and offer the most efficient and innovative therapies to all patients under the various conditions that might be forced upon them.},
}

Administration, Oral
Antineoplastic Agents/*administration & dosage/therapeutic use
Betacoronavirus
COVID-19
Carcinoma, Non-Small-Cell Lung/diagnosis/*therapy
Coronavirus Infections/*epidemiology
Disease Management
Humans
Lung Neoplasms/diagnosis/*therapy
Mediastinoscopy
Medical Oncology
Molecular Diagnostic Techniques
Neoplasm Staging
Pandemics
Pneumonia, Viral/*epidemiology
Quebec/epidemiology
Radiosurgery
*Radiotherapy
SARS-CoV-2
Small Cell Lung Carcinoma/diagnosis/*therapy
*Thoracic Surgical Procedures
Thoracoscopy
*Triage

@article {pmid32656798,
year = {2020},
author = {Craig, S and Cubitt, M and Jaison, A and Troupakis, S and Hood, N and Fong, C and Bilgrami, A and Leman, P and Ascencio-Lane, JC and Nagaraj, G and Bonning, J and Blecher, G and Mitchell, R and Burkett, E and McCarthy, SM and Rojek, AM and Hansen, K and Psihogios, H and Allely, P and Judkins, S and Foong, LH and Bernard, S and Cameron, PA},
title = {Management of adult cardiac arrest in the COVID-19 era: consensus statement from the Australasian College for Emergency Medicine.},
journal = {The Medical journal of Australia},
volume = {213},
number = {3},
pages = {126-133},
pmid = {32656798},
issn = {1326-5377},
mesh = {Adult ; Algorithms ; Australia/epidemiology ; Betacoronavirus ; COVID-19 ; Cardiopulmonary Resuscitation/*methods/standards ; Coronavirus Infections/*epidemiology/transmission ; Cross Infection/prevention & control ; Emergency Service, Hospital/*organization & administration ; Heart Arrest/*therapy ; Humans ; Infection Control/methods/standards ; Infectious Disease Transmission, Patient-to-Professional/prevention & control ; New Zealand/epidemiology ; *Pandemics ; Personal Protective Equipment ; Pneumonia, Viral/*epidemiology/transmission ; SARS-CoV-2 ; },
abstract = {INTRODUCTION: The global pandemic of coronavirus disease 2019 (COVID-19) has caused significant worldwide disruption. Although Australia and New Zealand have not been affected as much as some other countries, resuscitation may still pose a risk to health care workers and necessitates a change to our traditional approach. This consensus statement for adult cardiac arrest in the setting of COVID-19 has been produced by the Australasian College for Emergency Medicine (ACEM) and aligns with national and international recommendations.

MAIN RECOMMENDATIONS: In a setting of low community transmission, most cardiac arrests are not due to COVID-19. Early defibrillation saves lives and is not considered an aerosol generating procedure. Compression-only cardiopulmonary resuscitation is thought to be a low risk procedure and can be safely initiated with the patient's mouth and nose covered. All other resuscitative procedures are considered aerosol generating and require the use of airborne personal protective equipment (PPE). It is important to balance the appropriateness of resuscitation against the risk of infection. Methods to reduce nosocomial transmission of COVID-19 include a physical barrier such as a towel or mask over the patient's mouth and nose, appropriate use of PPE, minimising the staff involved in resuscitation, and use of mechanical chest compression devices when available. If COVID-19 significantly affects hospital resource availability, the ethics of resource allocation must be considered.

CHANGES IN MANAGEMENT: The changes outlined in this document require a significant adaptation for many doctors, nurses and paramedics. It is critically important that all health care workers have regular PPE and advanced life support training, are able to access in situ simulation sessions, and receive extensive debriefing after actual resuscitations. This will ensure safe, timely and effective management of the patients with cardiac arrest in the COVID-19 era.},
}

Adult
Algorithms
Australia/epidemiology
Betacoronavirus
COVID-19
Cardiopulmonary Resuscitation/*methods/standards
Coronavirus Infections/*epidemiology/transmission
Cross Infection/prevention & control
Emergency Service, Hospital/*organization & administration
Heart Arrest/*therapy
Humans
Infection Control/methods/standards
Infectious Disease Transmission, Patient-to-Professional/prevention & control
New Zealand/epidemiology
*Pandemics
Personal Protective Equipment
Pneumonia, Viral/*epidemiology/transmission
SARS-CoV-2

@article {pmid32643767,
year = {2020},
author = {Gralnek, IM and Hassan, C and Beilenhoff, U and Antonelli, G and Ebigbo, A and Pellisé, M and Arvanitakis, M and Bhandari, P and Bisschops, R and Van Hooft, JE and Kaminski, MF and Triantafyllou, K and Webster, G and Voiosu, AM and Pohl, H and Dunkley, I and Fehrke, B and Gazic, M and Gjergek, T and Maasen, S and Waagenes, W and de Pater, M and Ponchon, T and Siersema, PD and Messmann, H and Dinis-Ribeiro, M},
title = {ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: An update on guidance during the post-lockdown phase and selected results from a membership survey.},
journal = {Endoscopy},
volume = {52},
number = {10},
pages = {891-898},
pmid = {32643767},
issn = {1438-8812},
mesh = {Humans ; Betacoronavirus ; *Coronavirus Infections ; COVID-19 ; *Endoscopy, Gastrointestinal ; *Pandemics ; *Pneumonia, Viral ; SARS-CoV-2 ; Surveys and Questionnaires ; },
}